{"study_id": 43521, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could mitigate Clostridioides difficile infection (CDI)-induced colitis by protecting gut barrier integrity and reducing toxin production.", "results_summary": "UroA treatment attenuated CDI-induced colon epithelial damage, reduced inflammation, and preserved gut barrier integrity in mice. It also significantly decreased toxin expression and release from C. difficile without killing the bacteria, suggesting dual regulatory effects on both host and bacterial levels.", "population_specificity": "Preclinical model (mice) with CDI-induced colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:02.756866+00:00"}
{"study_id": 43523, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (Uro A) could remodel the tumor immune microenvironment and enhance the efficacy of anti-PD-1 immunotherapy in pancreatic ductal adenocarcinoma (PDAC).", "results_summary": "Uro A reduced stromal fibrosis, attenuated immunosuppressive M2-like macrophages, increased infiltration of CD4+ and CD8+ T cells, and improved overall survival when combined with anti-PD-1 therapy in a PDAC mouse model.", "population_specificity": "Genetically engineered mouse model (GEMM) of pancreatic ductal adenocarcinoma (PDAC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:03.260346+00:00"}
{"study_id": 43525, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to develop a physiologically-based pharmacokinetic (PBPK) model for Urolithin A (UA) to predict systemic concentrations and assess its safety and potential beneficial effects.", "results_summary": "The study established a PBPK model for UA, finding that concentrations associated with toxic or beneficial effects in vitro are unlikely to be achieved in vivo, supporting UA's safety but questioning the ease of achieving benefits through supplementation.", "population_specificity": "Human intervention studies (specific population details not provided).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:03.813689+00:00"}
{"study_id": 43526, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how Urolithin A (URO A) protects against doxorubicin (DOX)-induced liver injury in Wistar rats by examining its antioxidant, anti-inflammatory, and antiapoptotic mechanisms.", "results_summary": "URO A mitigated DOX-induced liver damage by elevating antioxidant enzymes (SOD, CAT), reducing inflammatory cytokines (TNF-\u03b1, NF-kB, IL-6), and altering apoptosis markers (caspase 3, cytochrome c oxidase). The results suggest URO A reduces oxidative stress, inflammation, and apoptosis in liver injury.", "population_specificity": "Wistar rats", "effective_dosage": "2.5 or 5 mg kg-1 d-1 (intraperitoneal)", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:05.189577+00:00"}
{"study_id": 43528, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate LPS-induced neuroinflammation, neural/synaptic damage, and cognitive deficits in mice, and to explore the underlying mechanisms involving the Sirt1/acetyl-NF-\u03baB pathway.", "results_summary": "UA administration significantly reduced cognitive deficits, neural loss, synaptic injury, glial cell activation, and proinflammatory cytokine production in LPS-exposed mice. These effects were mediated through Sirt1 expression and NF-\u03baB p65 deacetylation, and were abolished by a Sirt1 inhibitor.", "population_specificity": "Mice exposed to LPS-induced neuroinflammation", "effective_dosage": "200 mg kg-1 d-1 (intragastric administration)", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:05.281005+00:00"}
{"study_id": 43529, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of walnut polyphenols (WP) and Urolithin A (UroA) against H2O2-induced oxidative damage in human neuroblastoma cells and investigate the underlying mechanisms involving the PKA/CREB/BDNF signaling pathway.", "results_summary": "Both WP and UroA significantly reversed H2O2-induced cell damage, reduced oxidative stress markers, and upregulated the PKA/CREB/BDNF pathway, with these effects being abolished by a PKA inhibitor, indicating the pathway's critical role in their neuroprotective effects.", "population_specificity": "Human neuroblastoma (SH-SY5Y) cells", "effective_dosage": "UroA (5 and 10 \u03bcM)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:07.204066+00:00"}
{"study_id": 43531, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects and mechanisms of Urolithin A on gastric cancer progression in vitro and in vivo.", "results_summary": "Urolithin A suppressed gastric cancer cell proliferation, migration, and invasion while promoting apoptosis and inducing autophagy via the PI3K/AKT/mTOR pathway. In vivo, UA inhibited tumor growth, enhanced therapeutic effects, and reduced chemotherapy toxicity.", "population_specificity": "Gastric cancer cells (in vitro) and xenograft models (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:10.226652+00:00"}
{"study_id": 43530, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of Urolithin A (UA) intake on vascular endothelial function (VEF) and gut microbiome characteristics in non-UA producers with poor VEF.", "results_summary": "UA intake at 50 mg/day significantly increased gut microbiota alpha diversity and altered specific microbial genera. Improved VEF correlated with baseline FMD values and gut microbiota composition, suggesting UA's potential benefits for vascular health and gut environment.", "population_specificity": "Non-UA producers with relatively poor vascular endothelial function.", "effective_dosage": "10 mg/day and 50 mg/day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:11.256083+00:00"}
{"study_id": 43535, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent findings on innovative therapeutics for IBD, including the potential role of urolithin A.", "results_summary": "The abstract does not provide specific results on urolithin A's effects, only mentioning it as one of several microbiome-based therapies under investigation for IBD.", "population_specificity": "Not specified (general discussion of IBD patients).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:12.301374+00:00"}
{"study_id": 43533, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic potential of Urolithin A in cholangiocarcinoma (CCA) and elucidate its mechanisms, including autophagy.", "results_summary": "Urolithin A inhibited cell proliferation, induced G2/M phase cell cycle arrest, suppressed migration and invasion, and upregulated autophagy in CCA cells by suppressing the AKT/WNK1 signaling pathway. In xenograft mice, UA treatment inhibited tumor growth with increased LC3-II levels.", "population_specificity": "Cholangiocarcinoma (CCA) cells and xenograft mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:12.645329+00:00"}
{"study_id": 43534, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could promote nerve tissue regeneration and improve outcomes in peripheral nerve injury (PNI) using UA-loaded hydrogels in nerve guide conduits.", "results_summary": "UA-loaded hydrogels facilitated cell proliferation, reduced oxidative damage, and showed good biocompatibility. In vivo, UA improved sciatic functional index, electrophysiological outcomes, and muscle/nerve histology, performing comparably to autografts.", "population_specificity": "Rat models with sciatic nerve defects.", "effective_dosage": "Not specified (continuous release from hydrogels).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:12.873254+00:00"}
{"study_id": 43532, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could enhance anti-tumor T cell immunity by promoting T memory stem cell (TSCM) formation through mitophagy and Wnt signaling.", "results_summary": "UA administration in tumor-bearing mice improved anti-tumor CD8+ T cell immunity, and ex vivo UA-treated T cells showed enhanced anti-tumor function. UA-induced TSCM formation depended on Pink1-mediated mitophagy, leading to cytosolic Pgam5 release, \u03b2-catenin dephosphorylation, and Wnt signaling activation.", "population_specificity": "Tumor-bearing mice and ex vivo T cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:13.024172+00:00"}
{"study_id": 43536, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of CYP1A1 in Urolithin A-mediated gut barrier protection and immune regulation in inflammatory bowel disease (IBD).", "results_summary": "Urolithin A mitigated colitis in wildtype mice by improving gut barrier function and reducing inflammation, but these protective effects were absent in Cyp1a1 -/- mice. UroA also expanded T-reg cells in a CYP1A1-dependent manner.", "population_specificity": "C57BL/6 mice and Cyp1a1 -/- mice with DSS-induced acute colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:13.625144+00:00"}
{"study_id": 43537, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (Uro A) could attenuate the severity of alcoholic chronic pancreatitis (ACP) by suppressing the PI3K/AKT/mTOR signaling pathway.", "results_summary": "Urolithin A reduced acinar damage, suppressed AKT and P70S6K activation, and decreased pancreas-infiltrating macrophages and proinflammatory cytokines in mice with ACP, suggesting therapeutic potential for ACP patients with continued alcohol intake.", "population_specificity": "C57BL/6 mice with induced alcoholic chronic pancreatitis (ACP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:16.364842+00:00"}
{"study_id": 43538, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Urolithin A and a combination of Urolithin A+EGCG on mitochondrial and synaptic toxicities, inflammation, and behavioral changes in a mouse model of late-onset Alzheimer's disease.", "results_summary": "Urolithin A and the combination treatment improved behavioral outcomes, upregulated mitochondrial and synaptic genes, reduced mitochondrial dysfunction, increased dendritic spines, and decreased amyloid beta levels, with stronger effects observed in the combined treatment group.", "population_specificity": "Humanized homozygous amyloid beta knockin (hAbKI) mice modeling late-onset Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:18.786155+00:00"}
{"study_id": 43540, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could inhibit the replication of enterovirus 71 (EV71) and its potential as a treatment for EV71 infection.", "results_summary": "Urolithin A significantly inhibited EV71 replication in cells, outperforming ribavirin in terms of CC50, IC50, and selectivity index. It also promoted autophagy and apoptosis in infected cells, suggesting a potential therapeutic mechanism.", "population_specificity": "In vitro cell study (specific human population not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:20.434532+00:00"}
{"study_id": 43542, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A improves mitochondrial function in chondrocytes and alleviates osteoarthritis pathology in preclinical models and human cells.", "results_summary": "Urolithin A enhanced mitophagy and mitochondrial respiration in chondrocytes from healthy donors and OA patients, reduced cartilage degeneration, synovial inflammation, and pain in a mouse OA model, and improved joint mitochondrial health.", "population_specificity": "Primary chondrocytes from healthy donors and OA patients, and a mouse model of OA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:20.998656+00:00"}
{"study_id": 43539, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the inhibitory effect of Urolithin A on nasopharyngeal carcinoma (NPC) cells and its potential mechanism in vitro.", "results_summary": "Urolithin A inhibited NPC cell proliferation, migration, and invasion, induced apoptosis, and altered the ECM receptor interaction pathway. It also modulated various proteins related to apoptosis and epithelial-mesenchymal transition.", "population_specificity": "Nasopharyngeal carcinoma (NPC) cells (CNE2 cell line) in vitro.", "effective_dosage": "20-60 \u03bcM UroA, with specific effects noted at 40 \u03bcM.", "study_duration": "24 hours for RNA-sequencing; other assays' durations not specified.", "interactions": "Co-treatment with NAC (5 mM) reversed UroA's effects on apoptosis-related proteins.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:21.477282+00:00"}
{"study_id": 43541, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could alleviate fructose-induced hyperuricemic nephropathy in mice and explore its underlying mechanisms.", "results_summary": "UroA ameliorated fructose-induced kidney damage by reducing tubular hypertrophy, glomerular basement membrane thickening, and collagen deposition. It also suppressed STING-NLRP3-mediated inflammation and restored impaired mitophagy in nephropathic mice.", "population_specificity": "Mice with fructose-induced hyperuricemic nephropathy and human kidney-2 (HK-2) cells exposed to uric acid.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:21.744476+00:00"}
{"study_id": 43544, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the anti-inflammatory and anti-cancer effects of Urolithin A and explore its molecular mechanisms for potential clinical applications.", "results_summary": "Urolithin A demonstrated significant anti-inflammatory and anti-cancer effects in various in vitro and in vivo models, including colitis, carrageenan-induced edema, pancreatic cancer, and obesity. Its mechanisms involved modulation of aryl hydrocarbon receptors, protein phosphorylation, and p53 stabilization.", "population_specificity": "Animal models (rats, mice) and in vitro studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:21.832135+00:00"}
{"study_id": 43543, "supplement_id": 1643, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to summarize Urolithin A's metabolism, biological activity, and its potential therapeutic effects on pancreatic diseases by targeting inflammation, autophagy, and mitochondrial function.", "results_summary": "Urolithin A was found to activate autophagy, inhibit endoplasmic reticulum stress, reduce oxidative stress and inflammation, and improve mitochondrial function, suggesting potential benefits for pancreatic diseases like pancreatitis, pancreatic cancer, and diabetes.", "population_specificity": "Mammals (general, not human-specific)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:24.097137+00:00"}
{"study_id": 43545, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could protect against metabolic cardiomyopathy (MC) by restoring mitophagy in obese mice.", "results_summary": "UA significantly activated mitophagy, improved mitochondrial function, and ameliorated cardiac dysfunction and remodeling in obese mice. The protective effects of UA were dependent on PINK1/Parkin-mediated mitophagy, as inhibition or silencing of these pathways blunted UA's benefits.", "population_specificity": "Diet-induced obese mice and PA-challenged H9C2 cardiomyocytes.", "effective_dosage": "50 mg\u00b7kg-1\u00b7d-1 (mice), 5 \u03bcM (H9C2 cells)", "study_duration": "4 weeks (mice)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:26.733076+00:00"}
{"study_id": 43546, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (Uro-A) has protective effects against senile osteoporosis and to explore its underlying mechanisms.", "results_summary": "Uro-A inhibited osteoclastogenesis in bone marrow macrophages, reduced osteoclast-related gene expression and bone resorption, enhanced autophagy, and blocked the MARK signaling pathway. In aging mice, Uro-A effectively prevented bone loss in the proximal femur, spine, and tibia.", "population_specificity": "Bone marrow macrophages (BMMs) in vitro and aging mice in vivo.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:27.333885+00:00"}
{"study_id": 43547, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic potential of Urolithin A (UA) in preventing histamine-induced vascular damage in the retina, comparing it to paclitaxel and dexamethasone.", "results_summary": "Urolithin A significantly prevented vascular damage and apoptosis in the retina compared to the histamine-challenged group, showing efficacy similar to paclitaxel and better than dexamethasone. The results suggest UA could be a preventive strategy for retinal diseases.", "population_specificity": "Ex vivo rat eye model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:29.191837+00:00"}
{"study_id": 43549, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify potential targets, action networks, and mechanisms of Urolithin A (UA) in spinal cord injury (SCI) management using network pharmacology and molecular docking.", "results_summary": "The study identified 118 common UA-SCI targets, with key therapeutic targets including MAPK1, SRC, and AKT1. Molecular docking showed strong binding affinity between UA and target proteins, suggesting potential efficacy in SCI treatment.", "population_specificity": "In silico (computational) study, no human or animal subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:29.856413+00:00"}
{"study_id": 43550, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether urolithin A (UA) could mitigate cisplatin-induced acute kidney injury (AKI) by leveraging its anti-inflammatory and antioxidant properties.", "results_summary": "The abstract suggests UA may be beneficial in resolving inflammation and oxidative stress linked to cisplatin-induced AKI, but further testing is needed to ensure it does not stimulate tumor growth or reduce cisplatin's efficacy.", "population_specificity": "Not specified (likely preclinical models, given the context).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:29.949506+00:00"}
{"study_id": 43548, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could counteract mitophagy decline and prevent premature senescence in auditory cells.", "results_summary": "UA significantly reduced senescence markers (p53, p21) and increased mitophagy-related proteins, restored mitochondrial function (ATP content, mtDNA integrity, membrane potential), and reduced \u03b2-galactosidase-stained senescent cells in H2O2-induced senescent auditory cells and cochlear explants. Knockdown of mitophagy-related genes (Parkin, Bnip3) abolished UA's anti-senescent effects.", "population_specificity": "H2O2-induced senescent House Ear Institute-Organ of Corti 1 (HEI-OC1) cells and cochlear explants (in vitro model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:31.258905+00:00"}
{"study_id": 43551, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanisms of Urolithin A (UA) in promoting angiogenesis during wound healing, particularly in chronic and ischemic wounds.", "results_summary": "UA (5-20 \u03bcM) enhanced proliferation, migration, and angiogenic capacity of HUVECs in vitro and accelerated neovascularization and collagen remodeling in a full-thickness skin wound model in vivo, likely via inhibition of the PI3K/AKT pathway.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) and a full-thickness skin wound model (species not specified).", "effective_dosage": "5-20 \u03bcM (in vitro); dosage for in vivo not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:31.367430+00:00"}
{"study_id": 43552, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate diabetic retinopathy (DR) by reducing inflammation and oxidative stress via the Nrf2/HO-1 pathway.", "results_summary": "UA reduced blood glucose levels, decreased albumin and vascular endothelial growth factor concentrations, improved retinal structure damage, and inhibited inflammation and oxidative stress in diabetic rats and high glucose-induced human retinal endothelial cells. These effects were mediated through the Nrf2/HO-1 pathway.", "population_specificity": "Streptozotocin-induced diabetic rats and high glucose-induced human retinal endothelial cells (HRECs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:32.409822+00:00"}
{"study_id": 43554, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Urolithin A (UA) could mitigate diabetes-associated cognitive impairment in a type 2 diabetes mouse model by targeting systemic inflammation and gut barrier dysfunction.", "results_summary": "UA-treated mice showed reduced cognitive impairment, lower levels of metabolic endotoxemia and proinflammatory cytokines, and improved gut barrier function via upregulation of tight-junction proteins and N-glycan biosynthesis genes. UA's effects were independent of the gut microbiome and short-chain fatty acids, unlike metformin.", "population_specificity": "High-fat diet and streptozotocin-induced type 2 diabetes mellitus (T2DM) mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.506492+00:00"}
{"study_id": 43555, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Urolithin A on RANKL-induced osteoclast differentiation and its underlying molecular mechanisms, particularly in relation to osteoporosis.", "results_summary": "Urolithin A inhibited RANKL-induced osteoclast differentiation and bone resorption by regulating Akt1, p38, and ERK1/2 signaling pathways, with BMP2 identified as a potential mediator of these effects.", "population_specificity": "RAW264.7 cells (a murine macrophage cell line) and bone biopsy specimens.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:37.276070+00:00"}
{"study_id": 43553, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if Urolithin A, in combination with DHA and luteolin, could synergistically inhibit A\u03b21-42-induced toxicity in human neuroblastoma cells as a potential preventative therapy for Alzheimer's disease.", "results_summary": "Urolithin A, when combined with DHA and luteolin (D5L5U5), was found to be the most effective at inhibiting A\u03b21-42-induced toxicity in human neuroblastoma cells, demonstrating synergistic effects. The combination showed potential as a basis for developing functional foods for Alzheimer's prevention or co-treatment.", "population_specificity": "Human neuroblastoma BE(2)-M17 cells", "effective_dosage": "D5L5U5 (specific amounts not detailed in abstract)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:37.685140+00:00"}
{"study_id": 43557, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) affects the cardiac myofibroblast transformation (CMT) process during myocardial fibrosis and its underlying mechanism.", "results_summary": "UA treatment inhibited the CMT process in TGF-\u03b21-induced cardiac fibroblasts, reducing proliferation, migration, and invasion. In vivo, UA administration improved myocardial damage and fibrosis by activating the Nrf2 pathway.", "population_specificity": "Primary rat cardiac fibroblasts (in vitro) and a rat myocardial infarction model (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:38.338782+00:00"}
{"study_id": 43556, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate traumatic brain injury (TBI) in mice and explore its potential neuroprotective mechanisms.", "results_summary": "UA reduced brain edema, enhanced tight junction protein expression, increased autophagy markers (LC3 and p62), downregulated PI3K/Akt/mTOR and Akt/IKK/NF\u03baB pathways, decreased neuroinflammation, reduced blood-brain barrier permeability and neuronal apoptosis, and improved neurological function in TBI mice.", "population_specificity": "Adult C57BL/6J mice with induced traumatic brain injury.", "effective_dosage": "Not specified (intraperitoneal administration).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:39.471729+00:00"}
{"study_id": 43559, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could alleviate senescence in nucleus pulposus-derived mesenchymal stem cells (NPMSCs) and intervertebral disc degeneration (IDD) by activating the SIRT1/PGC-1\u03b1 pathway.", "results_summary": "UA significantly reduced senescence markers in NPMSCs exposed to oxidative stress, improved mitochondrial function via the SIRT1/PGC-1\u03b1 pathway, and alleviated IDD in an animal model.", "population_specificity": "Rat-derived NPMSCs and an animal model of IDD.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:40.196494+00:00"}
{"study_id": 43558, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could protect against inorganic arsenic (iAs3+)-induced gut barrier dysfunction, oxidative stress, and inflammation.", "results_summary": "UroA attenuated iAs3+-induced cell toxicity, apoptosis, oxidative stress, and gut barrier permeability in colon epithelial cells and a human intestinal 3D organoid model. It also reduced inflammatory markers and preserved tight junctional proteins.", "population_specificity": "Colon epithelial cells and human intestinal 3D organoids (in vitro models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:40.409992+00:00"}
{"study_id": 43560, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate dopaminergic neurodegeneration and neuroinflammation in Parkinson's disease (PD) by promoting mitophagy in microglia.", "results_summary": "UA reduced dopaminergic neuron loss, improved behavioral deficits, and attenuated neuroinflammation in an MPTP mouse model of PD. It also promoted mitophagy, restored mitochondrial function, and reduced NLRP3 inflammasome activation in BV2 microglial cells and in vivo.", "population_specificity": "MPTP mouse model of Parkinson's disease and BV2 microglial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:41.332970+00:00"}
{"study_id": 43564, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore Urolithin A's potential neuroprotective properties, particularly its ability to induce mitophagy, as a therapeutic approach for Alzheimer's disease.", "results_summary": "The abstract highlights Urolithin A's antioxidant, anti-inflammatory, anti-atherogenic, anti-A\u03b2, and pro-mitophagy properties, suggesting potential benefits for mitochondrial health in Alzheimer's disease, though the mechanisms remain poorly understood.", "population_specificity": "Not specified (focus on Alzheimer's disease and aging-related mitochondrial dysfunction).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:46.268249+00:00"}
{"study_id": 43562, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could protect against renal ischemia reperfusion (RIR) injury by alleviating oxidative stress and promoting autophagy via the p62-Keap1-Nrf2 signaling pathway.", "results_summary": "UA reduced apoptosis of tubular cells and lowered reactive oxygen species (ROS) levels in a mouse RIR model. It also decreased p62 and Keap1 expression while increasing nuclear Nrf2, indicating activation of the p62-Keap1-Nrf2 pathway.", "population_specificity": "Mouse model of renal ischemia reperfusion injury and in vitro hypoxia cell model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:46.493649+00:00"}
{"study_id": 43563, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the potential neuroprotective role of Urolithin A (UA) in Parkinson's disease (PD) by examining its effects on mitochondrial dysfunction and dopaminergic neurotoxicity in cell cultures and a mouse model.", "results_summary": "UA protected against 6-OHDA-induced cytotoxicity and apoptosis in PC12 cells, ameliorated motor deficits and dopaminergic neurotoxicity in mice, and attenuated mitochondrial dysfunction by enhancing mitochondrial biogenesis via the SIRT1-PGC-1\u03b1 pathway.", "population_specificity": "PC12 cells (a rat neuronal cell line) and 6-OHDA-lesioned mice (a model of Parkinson's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:47.402602+00:00"}
{"study_id": 43561, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to determine whether oral Urolithin A supplementation improves 6-minute walk distance, muscle endurance, and mitochondrial/cellular health biomarkers in older adults.", "results_summary": "Urolithin A significantly improved muscle endurance and reduced plasma biomarkers associated with mitochondrial dysfunction, but did not significantly improve 6-minute walk distance or maximal ATP production compared to placebo.", "population_specificity": "Adults aged 65-90 years, predominantly women (75.8%), all White individuals.", "effective_dosage": "1000 mg daily", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:47.648329+00:00"}
{"study_id": 43565, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could inhibit glioblastoma cell proliferation, migration, and invasion by regulating the Sirt1-FOXO1 axis.", "results_summary": "UA suppressed glioblastoma cell proliferation, migration, invasion, and EMT in a time- or dose-dependent manner, induced cell cycle arrest and apoptosis, and upregulated Sirt1 and FOXO1 expression. In vivo, UA reduced tumor size and weight in xenograft mice while enhancing Sirt1 and FOXO1 expression.", "population_specificity": "Glioblastoma cells (U251, U118 MG) and immunodeficient mice with implanted GBM cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:49.070149+00:00"}
{"study_id": 43567, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) enhances osteoblast proliferation and bone repair in mice with bone defects by activating the Wnt pathway.", "results_summary": "UA increased mineralization and osteogenic gene markers in mesenchymal stem cells (MSCs) in vitro and improved bone defect scores, bone mineral density, and Wnt3a protein levels in bone-defect mice.", "population_specificity": "Mice with induced middle femoral defects and isolated MSCs.", "effective_dosage": "10, 25, and 50 \u00b5g/mL in vitro; dosage in vivo not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:49.626003+00:00"}
{"study_id": 43568, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to investigate Urolithin A's neuroprotective effects, particularly its impact on mitochondrial function and autophagy, in a cellular model of early Alzheimer's disease.", "results_summary": "Urolithin A showed no effect on autophagy but induced transcription of genes related to mitochondrial biogenesis. It reduced mitochondrial membrane potential and ATP levels at 10 \u00b5M but did not affect ROS or A\u03b2 levels at 1 \u00b5M.", "population_specificity": "SH-SY5Y-APP695 cells (a cellular model of early Alzheimer's disease) and SH-SY5Ymock controls.", "effective_dosage": "1 \u00b5M and 10 \u00b5M, single treatment.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:50.777931+00:00"}
{"study_id": 43566, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect and mechanism of Urolithin A (UA) on inflammation and lipid accumulation induced by hyperlipidemia in L02 hepatocytes, focusing on the Nrf2 pathway and autophagy.", "results_summary": "UA reversed the inflammatory and oxidative stress effects of free fatty acids (FFAs) in L02 cells, reducing lipid accumulation, TNF-\u03b1, IL-6, ROS, and MDA levels while increasing SOD2, CAT, and autophagy markers. These effects were mediated by the Nrf2 pathway, as they disappeared when Nrf2 was knocked down.", "population_specificity": "L02 hepatocytes (a human liver cell line)", "effective_dosage": "10 \u03bcmol/L (low dose) and 20 \u03bcmol/L (high dose)", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:51.617443+00:00"}
{"study_id": 43570, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could protect chondrocytes from mechanical overloading-induced cartilage degradation by enhancing mitophagy and reducing senescence.", "results_summary": "UA treatment significantly improved cartilage matrix deposition and quality while suppressing senescence levels induced by mechanical overloading, functioning partially through enhanced mitophagy.", "population_specificity": "Human chondrocytes cultured in hyaluronic hydrogel.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:54.022334+00:00"}
{"study_id": 43571, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antileukemic activities of urolithin A and B, focusing on their effects on leukemic cell proliferation, metabolism, and apoptosis.", "results_summary": "Urolithin A and B significantly inhibited the proliferation of leukemic cell lines Jurkat and K562, with urolithin A showing stronger antiproliferative effects. Both compounds altered leukemic cell metabolism and promoted apoptosis.", "population_specificity": "Leukemic cell lines (Jurkat and K562)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.299978+00:00"}
{"study_id": 43572, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review the biological effects and translational potential of Urolithin A as a nutritional intervention for aging and age-related conditions.", "results_summary": "Urolithin A enhances cellular health by promoting mitophagy, improving mitochondrial function, and reducing inflammation. Preclinical and clinical studies suggest it protects against aging-related conditions in muscles, brain, and joints, with clinical trials supporting benefits in elderly muscle health.", "population_specificity": "Elderly people (clinical trials), preclinical models (animal/cellular studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.920025+00:00"}
{"study_id": 43569, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could improve the developmental potential of bovine oocytes and granulosa cells by mitigating oxidative stress and mitochondrial dysfunction, particularly in aged oocytes.", "results_summary": "UA treatment enhanced maturation rates, mitochondrial membrane potential, and developmental competence in aged bovine oocytes, while also positively influencing gene expression (NFE2L2, NQO1) in granulosa cells. The study demonstrated UA's effectiveness in preventing oocyte aging and improving subsequent embryonic development.", "population_specificity": "Bovine cumulus-oocyte-complexes (COCs) and granulosa cells (GCs) from prepubertal and adult females.", "effective_dosage": "Not specified", "study_duration": "22 hours (physiological maturation) and 30 hours (in vitro aged oocytes)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:56.131389+00:00"}
{"study_id": 43574, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review recent updates on Urolithin A's anti-inflammatory function and summarize its potential mechanisms for attenuating immunometabolic diseases in a tissue-specific manner.", "results_summary": "The study found that Urolithin A administration attenuates inflammation in various tissues (brain, adipose, heart, liver) and may delay or prevent diseases like Alzheimer's, type 2 diabetes, and non-alcoholic fatty liver disease. It highlights UroA's potential as an anti-inflammatory molecule through dietary or pharmaceutical intervention.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:58.409907+00:00"}
{"study_id": 198530, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the prevalence of Urolithin A (UA) producers in a healthy population and assess whether direct UA supplementation could overcome microbiome and dietary variability.", "results_summary": "Only 12% of subjects had detectable UA at baseline, while ~40% converted precursor compounds into UA after pomegranate juice intake. Direct UA supplementation significantly increased plasma levels, providing >6-fold exposure compared to pomegranate juice.", "population_specificity": "Healthy participants (n=100)", "effective_dosage": "500 mg UA", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:59.613985+00:00"}
{"study_id": 43573, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of Urolithin A on cell behavior related to endometriosis, including growth, adhesion, motility, and invasion in vitro.", "results_summary": "Urolithin A significantly decreased cell proliferation, increased apoptosis, reduced migration and invasion, and downregulated genes related to proteolysis and cell adhesion in endometriotic cells. It also inhibited viability and development in 3D spheroids and organoids.", "population_specificity": "Primary endometriotic stromal cells from 6 patients, immortalized endometrial stromal (St-T1b) and endometriotic epithelial cells (12Z), and organoids from 3 donors with endometriosis.", "effective_dosage": "40 \u00b5M UA (proliferation, apoptosis, migration, invasion), 80 \u00b5M UA (spheroid viability, area, integrity), 33.93 \u00b5M UA (organoid IC50).", "study_duration": "Not specified (in vitro assays).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:00.117076+00:00"}
{"study_id": 198529, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the link between gut microbiota alterations, including urolithin A production, and sarcopenia in aging populations.", "results_summary": "The study found decreased abundance of gut microbiota involved in urolithin A production in sarcopenic individuals, suggesting a potential role of urolithin A in the gut-muscle axis pathway. Supplementation with beneficial microorganisms linked to urolithin A production may help mitigate muscle atrophy and slow sarcopenia progression.", "population_specificity": "Elderly humans (aged 57-98) with sarcopenia or at risk, and animal models (mice and rats).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:00.512842+00:00"}
{"study_id": 198531, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore Urolithin A as a potential pharmacological strategy for treating sarcopenia in chronic liver disease (CLD).", "results_summary": "The abstract suggests Urolithin A may be useful for treating age-related sarcopenia and potentially CLD-related sarcopenia, but no specific results or data are provided.", "population_specificity": "Patients with chronic liver disease (CLD) and sarcopenia, though the abstract also mentions age-related sarcopenia.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:02.301115+00:00"}
{"study_id": 42677, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the radioprotective effects of UA312, an optimized derivative of Ursolic Acid, on radiation-induced developmental toxicity in zebrafish embryos and larvae.", "results_summary": "UA312 (40 \u00b5M) restored IR-induced developmental dysplasia in zebrafish, reversed neurodevelopmental and cardiotoxicity pathways, and improved locomotor behavior by targeting chrna3 and grik5.", "population_specificity": "Zebrafish embryos and larvae", "effective_dosage": "40 \u00b5M", "study_duration": "Observations at 4, 24, 48, and 72 hours post-fertilization (hpf)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:04.778925+00:00"}
{"study_id": 42676, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to elucidate the molecular mechanism by which Ursolic Acid (UA) exerts its anticancer effects in nasopharyngeal carcinoma (NPC) cells, focusing on apoptosis induction via the P53 signaling pathway.", "results_summary": "UA dose-dependently inhibited NPC cell proliferation and induced apoptosis by activating the P53 pathway, upregulating pro-apoptotic BAX, and downregulating anti-apoptotic Bcl-2. Mitochondrial membrane depolarization and nuclear condensation confirmed apoptotic effects.", "population_specificity": "Nasopharyngeal carcinoma (NPC) cell lines S18 and S26.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:04.820197+00:00"}
{"study_id": 42678, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Ursolic Acid (UA) alleviates sarcopenia by modulating the IL-17a-related gut-muscle axis and improving muscle function.", "results_summary": "UA significantly improved gut microbiota diversity, restored short-chain fatty acid levels, enhanced muscle quality and function, and suppressed the IL-17a signaling pathway in sarcopenic mice. In vitro, UA inhibited TNF-\u03b1-induced myotube atrophy and reduced markers of muscle degradation.", "population_specificity": "Diabetic sarcopenic mice and TNF-\u03b1-treated C2C12 myotubes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:06.116473+00:00"}
{"study_id": 42679, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the combined effect of Ursolic Acid (UA) and Caprylic Acid (CA) on PTZ-induced seizures, neuronal damage, and inflammation in adult zebrafish.", "results_summary": "The combination of UA (50 mg/kg) and CA (60 mg/kg) significantly reduced seizure-like behaviors, oxidative stress, mitochondrial dysfunction, and neuronal damage in PTZ-treated zebrafish, with effects comparable to Diazepam. The treatment also lowered inflammatory markers and improved antioxidant defenses.", "population_specificity": "Adult zebrafish (~6-8 months old; 470-530 mg)", "effective_dosage": "UA (50 mg/kg and 150 mg/kg, single dose), CA (60 mg/kg, single dose)", "study_duration": "Single-dose intervention with assessments conducted 30 minutes post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:07.997066+00:00"}
{"study_id": 42680, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-proliferative and anti-parasitic properties of ursolic acid (UA) in Theileria annulata-infected bovine cells, including its efficacy against drug-resistant strains.", "results_summary": "UA demonstrated selective cytotoxicity toward infected cells (IC50 ~5 \u03bcg/mL), induced apoptosis via DNA damage, ROS elevation, and mitochondrial disruption, and showed consistent efficacy against both BPQ-sensitive and BPQ-resistant strains. Proteomic and Western blot analyses revealed UA's modulation of host cell pathways and parasite metabolic processes.", "population_specificity": "Theileria annulata-infected bovine cells (TA cells)", "effective_dosage": "IC50 of approximately 5 \u03bcg/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:08.769489+00:00"}
{"study_id": 42681, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how ursolic acid modulates estrogen conversion via HSD17B14 to alleviate inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD).", "results_summary": "Ursolic acid reduced HSD17B14 and estrone (E1) levels while increasing 17\u03b2-estradiol (E2), mitigating inflammation in steatotic hepatocytes. E1 promoted inflammation, whereas E2 had anti-inflammatory effects, which were counteracted by HSD17B14.", "population_specificity": "Murine models with MASLD induced by a western diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:09.046146+00:00"}
{"study_id": 42682, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic potential of Ursolic Acid in Hashimoto's thyroiditis (HT) by examining its effects on immune balance, gut microbiota, and ferroptosis in an experimental autoimmune thyroiditis (EAT) rat model.", "results_summary": "Ursolic Acid suppressed HT inflammation by reducing IL-17A, TNF-\u03b1, and ROS levels, modulating Th17/Treg cell balance, improving gut microbiota composition (increasing Lactobacillus and Bifidobacterium), and regulating ferroptosis-related gene expression.", "population_specificity": "Experimental autoimmune thyroiditis (EAT) rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:09.062774+00:00"}
{"study_id": 42683, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the inhibitory effects of ursolic acid (UA) derivatives on tumor cell proliferation and their potential as leading compounds for cancer therapy.", "results_summary": "The study found that UA derivatives, particularly compounds IV and X, effectively inhibited proliferation in HeLa, SKOV3, BGC-823, and HT1080 tumor cells, outperforming Gefitinib and showing effects similar to Vp-16. Mechanistically, these compounds may trigger apoptosis by activating Sp1 to inhibit Survivin protein expression.", "population_specificity": "In vitro tumor cell lines (HeLa, SKOV3, BGC-823, HT1080).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:12.060813+00:00"}
{"study_id": 42685, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of nanotechnology-enhanced delivery of ursolic acid (UA) for targeted anti-ageing skin cell treatment.", "results_summary": "The study found that encapsulating UA in biocompatible nanocarriers improved its stability, dermal penetration, and sustained release, leading to enhanced absorption in deeper skin layers and effective anti-ageing treatment.", "population_specificity": "Not specified (likely in vitro or preclinical study based on abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:12.621365+00:00"}
{"study_id": 42684, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antifungal activity and disease resistance mechanisms induced by ursolic acid (UA) in apple fruit against Penicillium expansum.", "results_summary": "UA demonstrated direct antifungal activity by inhibiting P. expansum growth and spore germination in vitro (IC50: 175.6 mg L-1). It also induced disease resistance in apple fruit by activating defensive enzymes, antioxidative pathways, and the phenylpropanoid pathway, leading to increased phenolic, flavonoid, and lignin contents.", "population_specificity": "Apple fruit (postharvest)", "effective_dosage": "175.6 mg L-1 (IC50 for hyphal growth)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.203819+00:00"}
{"study_id": 42686, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to comprehensively review the therapeutic benefits of Ursolic Acid, including its pharmacological properties and potential uses in treating various illnesses.", "results_summary": "The study found that Ursolic Acid exhibits anti-inflammatory, antioxidant, anticancer, antibacterial, and metabolic-regulating properties, with potential benefits for treating cancer, neurological disorders, metabolic disorders, and cardiovascular diseases. It also highlighted its role as an exercise mimic.", "population_specificity": "Not specified (broad review of pharmacological properties).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.953325+00:00"}
{"study_id": 42688, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic efficacy of Ursolic Acid (UA) in treating periodontitis and to elucidate its underlying mechanisms, particularly its role in the RIPK3/NLRP3 signaling pathway.", "results_summary": "UA significantly reduced periodontal damage, alveolar bone resorption, and inflammatory factor expression. It exerted anti-inflammatory effects by binding to RIPK3 and inhibiting the NLRP3 inflammasome pathway.", "population_specificity": "Animal models (specific species not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:16.598462+00:00"}
{"study_id": 42690, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to develop novel Ursolic Acid derivatives with enhanced antibacterial properties, particularly against methicillin-resistant Staphylococcus aureus (MRSA).", "results_summary": "UA derivatives 27 and 34 demonstrated strong antibacterial activity against MRSA (MICs of 1 \u03bcM), low hemolytic activity, non-resistance, low toxicity to mammalian cells, and the ability to inhibit MRSA biofilm formation. They also showed promising in vivo efficacy in a mouse wound model.", "population_specificity": "Methicillin-resistant Staphylococcus aureus (MRSA) and a mouse wound model.", "effective_dosage": "MIC of 1 \u03bcM for derivatives 27 and 34.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:17.640692+00:00"}
{"study_id": 42689, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess how ursolic acid (UA) protects human skin keratinocytes from UVB radiation-induced damage and its potential to reverse metabolic, epigenetic, and transcriptomic alterations.", "results_summary": "UA reversed UVB-induced metabolic changes (e.g., creatinine, creatine phosphate, succinic acid levels), modulated gene expression (e.g., S100A9, IL6 receptor), and partially restored UVB-induced CpG methylation alterations. It also influenced glycerophospholipid metabolism by regulating key enzymes.", "population_specificity": "Human skin keratinocytes (HaCaT cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:18.289910+00:00"}
{"study_id": 42687, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Ursolic Acid (UA) enhances the sensitivity of esophageal squamous cell carcinoma (ESCC) cells to radiotherapy by modulating ferroptosis through the p53/SLC7A11/GPX4 pathway.", "results_summary": "UA reduced ESCC cell viability and enhanced the effects of ionizing radiation by suppressing proliferation, migration, and invasion, while inducing cell death and ferroptosis. The combination of UA and IR activated the p53/SLC7A11/GPX4 pathway, improving radiotherapy responsiveness in vitro and in vivo.", "population_specificity": "Esophageal squamous cell carcinoma (ESCC) cells (TE-1 and KYSE30) and a subcutaneous graft tumor model in nude mice.", "effective_dosage": "10 \u03bcM UA", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:19.004103+00:00"}
{"study_id": 42692, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the mechanism by which ursolic acid (UA) exerts its antifibrotic effects in liver fibrosis, particularly its role in modulating the NOX2/NLRP3 inflammasome signaling pathway and gut microbiota.", "results_summary": "UA attenuated liver injury and fibrosis, reduced fibrosis-related indices, and decreased NOX2 and NLRP3 expression. It also improved gut microbiota diversity, increasing beneficial bacteria and reducing harmful bacteria, suggesting its antifibrotic effects are mediated through the NOX2/NLRP3 pathway.", "population_specificity": "Liver fibrosis models in mice (MCD diet and CCl4-induced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:21.545250+00:00"}
{"study_id": 42691, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the synergistic potential of Ursolic Acid (UA) and Solasodine (Sol) in treating colorectal cancer (CRC) by investigating their effects on apoptosis, autophagy, and metastasis via the AKT1/ERK1/2-GSK-3\u03b2-\u03b2-catenin axis.", "results_summary": "The UA-Sol combination synergistically inhibited CRC cell viability at a 6:24 molar ratio, induced apoptosis and autophagy, and inhibited metastasis by targeting AKT1 and ERK1/2, thereby regulating GSK-3\u03b2 and \u03b2-catenin.", "population_specificity": "Colorectal cancer cells (in vitro) and mouse xenograft tumor and lung metastasis models (in vivo).", "effective_dosage": "Molar ratio of 6:24 (UA-Sol).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.326296+00:00"}
{"study_id": 42693, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory, anti-arthritic, and hepatoprotective effects of ursolic acid derived from Atylosia goensis.", "results_summary": "Ursolic acid significantly reduced joint edema and attenuated disease-associated biomarkers in a dose-dependent manner, demonstrating anti-inflammatory and anti-arthritic effects. It also showed hepatoprotective potential by mitigating liver dysfunction and reducing inflammatory areas in histopathological assessments.", "population_specificity": "Animal model (specific species not mentioned in the abstract).", "effective_dosage": "200 and 400 mg/kg.", "study_duration": "24 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:23.620214+00:00"}
{"study_id": 42694, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether hyaluronic acid-coated ursolic acid nanoparticles (HA-PEG-UA NPs) could effectively target and inhibit neuronal ferroptosis in a subarachnoid hemorrhage (SAH) model, improving neurological outcomes.", "results_summary": "HA-PEG-UA NPs successfully targeted the SAH-affected brain region, inhibited neuronal ferroptosis, improved neurological deficits, and activated the Nrf-2/SLC7A11/GPX4 signaling pathway. The targeted delivery of ursolic acid enhanced its therapeutic potential in SAH.", "population_specificity": "Mice with induced subarachnoid hemorrhage (SAH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:24.381321+00:00"}
{"study_id": 42695, "supplement_id": 1644, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of Ursolic Acid (UA) and Oleanolic Acid (OA) at low doses (5 \u00b5M to 10 \u00b5M) in inducing cytotoxicity in breast cancer cells and their safety in non-tumorigenic cells.", "results_summary": "UA and OA, alone or in combination, effectively killed breast cancer cells at low doses (\u226410 \u00b5M) with minimal toxicity to non-tumorigenic cells. The cytotoxicity was linked to excessive autophagy rather than apoptosis, and the inhibition of PI3K/Akt/mTOR pathways played a key role.", "population_specificity": "Breast cancer cell lines (MCF7 and MDA-MB231) and a non-tumorigenic cell line (MCF-12A).", "effective_dosage": "5 \u00b5M to 10 \u00b5M", "study_duration": "Not specified", "interactions": "Synergistic effect noted with PI3K inhibitor (LY294002).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:27.005325+00:00"}
{"study_id": 42697, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the medicinal efficacy of Ursolic Acid (UA) and its mechanism of action in counteracting skeletal muscle atrophy in a murine model.", "results_summary": "UA supplementation effectively restored body weight and myotube diameter, reduced oxidative stress markers (ROS, LPO, caspase-3-like activity), and lowered pro-inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1, TWEAK). It also upregulated antioxidant enzymes (SOD, GPx) and key regulatory proteins (PGC-1\u03b1, Bcl2, p-Aktser473).", "population_specificity": "Murine (mouse) model with denervation-induced skeletal muscle atrophy.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:27.565915+00:00"}
{"study_id": 42696, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the synergistic anticancer effects and biosafety of ursolic acid when combined with dacarbazine in a biomimetic nanomedicine for melanoma therapy.", "results_summary": "The study found that the red blood cell membrane-encapsulated nanoparticles (RNPs) containing ursolic acid and dacarbazine exhibited superior anticancer ability, biosafety, and induced ferroptosis in tumor cells, with ferroptosis inhibition partially rescuing melanoma cells from RNPs-induced death.", "population_specificity": "Xenograft tumor models (in vivo) and melanoma cells (in vitro).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:28.513135+00:00"}
{"study_id": 42698, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ursolic acid nanofibers (UANFs) could improve the water solubility, bioavailability, and anti-breast cancer efficacy of ursolic acid (UA).", "results_summary": "UANFs significantly improved UA's water solubility and skin penetration, enhanced anti-breast cancer activity by inhibiting STAT3 and ERK1/2 phosphorylation, and induced caspase-3 cleavage, unlike raw UA. The study suggests UANFs could be a promising treatment for breast cancer, though further efficacy and safety trials are needed.", "population_specificity": "Not specified (implied focus on breast cancer patients with fungating wounds).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:28.580088+00:00"}
{"study_id": 42699, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the protective effects of Ursolic Acid (UA) on alcohol-induced liver injury and elucidate its mechanism of action, particularly regarding ferroptosis and gut microbiota regulation.", "results_summary": "UA significantly protected against alcohol-induced liver injury in mice by reducing serum markers of liver damage, improving oxidative stress, regulating lipid metabolism, and inhibiting ferroptosis. It also improved gut microbiota imbalance and showed protective effects in alcohol-treated HepG2 cells.", "population_specificity": "Mice (animal model) and HepG2 cells (cellular model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:30.704172+00:00"}
{"study_id": 42700, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether RCDs/UA@Lipo-HAMA, a hydrogel containing ursolic acid (UA) and carbon dots, could reduce tendon adhesion and enhance healing by mitigating oxidative stress, inflammation, and fibrosis.", "results_summary": "The study found that RCDs/UA@Lipo-HAMA effectively reduced oxidative stress, inflammation, and fibrosis, improved collagen arrangement and biomechanical properties, and promoted motor function recovery in tendon injury models.", "population_specificity": "Rat models with Achilles tendon injury (ATI) and flexor digitorum profundus tendon injury (FDPI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:31.879954+00:00"}
{"study_id": 42702, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the biological activities of Ursolic Acid (UA) and its derivatives, focusing on their pharmacological properties, structure-activity relationships, molecular targets, and modes of action.", "results_summary": "The study found that UA and its derivatives exhibit diverse biological activities, including anticancer, antifungal, antidiabetic, antioxidant, antibacterial, anti-inflammatory, and antiviral properties, supported by in vitro and in vivo studies.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:33.886250+00:00"}
{"study_id": 42701, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of ursolic acid (UA) on Angiotensin II-induced cardiac fibrosis in neonatal rat cardiac fibroblasts (rCFs).", "results_summary": "UA significantly reduced fibrosis markers (hydroxyproline, Col1a1, Col3a1, Tgfb1, Acta2, Mmp2) and increased antioxidant markers (Nrf2, HO-1) in a dose- and time-dependent manner, demonstrating antiapoptotic, antioxidant, and cardioprotective properties.", "population_specificity": "Neonatal rat cardiac fibroblasts (rCFs) isolated from two-day-old rats.", "effective_dosage": "5 and 10 \u03bcM UA for 24 and 48 hours.", "study_duration": "24 and 48 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:34.156137+00:00"}
{"study_id": 42703, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to uncover the molecular mechanisms by which Ursolic Acid (UA) affects mast cells and its potential antipruritic effects, focusing on its modulation of TRPV4, PAR2, and MRGPRX2/MrgprB2.", "results_summary": "UA significantly suppressed MRGPRX2/MrgprB2 activation, reduced mast cell degranulation, and decreased tryptase and TSLP production in a dry skin mouse model. It also attenuated scratching behaviors, suggesting potential as an antipruritic agent.", "population_specificity": "Dry skin mouse model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:36.439651+00:00"}
{"study_id": 42704, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate ursolic acid as a novel inhibitor of TMEM16A in lung cancer and assess its efficacy in combination with cisplatin using a hydrogel drug-loading system.", "results_summary": "Ursolic acid inhibited TMEM16A (IC50 = 13.85 \u00b1 1.64 \u03bcM), suppressed lung cancer cell proliferation and migration, and promoted apoptosis via MAPK and EMT pathways. The hydrogel-loaded combination with cisplatin enhanced antitumor activity and reduced toxicity in vivo.", "population_specificity": "LA795 lung cancer cells (in vitro) and in vivo models (specific organism not stated).", "effective_dosage": "Not specified (IC50 provided for TMEM16A inhibition).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:37.952236+00:00"}
{"study_id": 42705, "supplement_id": 1644, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of UA-loaded PLGA nanoparticles (UA-PLGA NPs) in overcoming the poor solubility and bioavailability of ursolic acid (UA) for treating cholangiocarcinoma (CCA).", "results_summary": "UA-PLGA NPs demonstrated high encapsulation efficiency (98%), good stability, biocompatibility, and cytotoxic effects on CCA cells, even without organic solvents like DMSO, suggesting improved delivery and efficacy of UA for CCA treatment.", "population_specificity": "Cholangiocarcinoma (CCA) cell lines (KKU-213A and KKU-055).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:38.062652+00:00"}
{"study_id": 42706, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the therapeutic potential of Ursolic Acid (UA) against gastrointestinal cancer, focusing on its anti-inflammatory, anti-proliferative, and anti-metastatic properties, as well as the challenges of its low bioavailability and potential solutions through nanoformulations.", "results_summary": "UA demonstrated anti-cancer properties by modulating critical signaling pathways, but its clinical use is limited by low oral bioavailability. Nanoformulations like liposomes and polymer micelles could enhance its stability and efficacy, though further clinical validation is needed.", "population_specificity": "Gastrointestinal cancer (general, no specific subpopulation mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:38.127898+00:00"}
{"study_id": 42707, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the potential targets and mechanisms of Ursolic Acid (UA) in treating Parkinson's Disease (PD) using network pharmacology, molecular docking, and experimental methods.", "results_summary": "UA demonstrated favorable binding affinity with key targets (CASP8, IL1B, CASP3, TNF, MAPK3, IL6), ameliorated motor dysfunction in PD mice, increased tyrosine hydroxylase (TH) expression, and reduced pro-inflammatory and apoptotic markers in PD cell models.", "population_specificity": "PD mice model and PD cell models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:39.584140+00:00"}
{"study_id": 42708, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the bioactivity and antiproliferative effects of newly synthesized Ursolic Acid (UA) conjugates against cancer cell lines, particularly Triple Negative Breast Cancer (TNBC) and bladder cancer.", "results_summary": "The synthesized UA conjugates showed moderate to significantly enhanced antiproliferative activity against TNBC (MDA-MB 231) and bladder cancer (T24 and 5637) cell lines, with compounds 18c and 18d demonstrating promising cytotoxicity. Compound 18d exhibited selective cytotoxicity toward cancer cells over normal epithelial cells and worked through multiple mechanisms, including drug-induced autophagy and programmed cell death.", "population_specificity": "Mammalian cells and animal models of cancers (specifically TNBC and bladder cancer cell lines).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:42.053968+00:00"}
{"study_id": 42709, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the regulatory mechanism of podocyte injuries in diabetic nephropathy (DN) progression and the protective function of ursolic acid (UA) treatment against DN progression.", "results_summary": "UA treatment reduced DN progression by improving biochemical indices and ameliorated P62 accumulation-induced mitotic catastrophe in podocytes through enhanced autophagy. The protective effects of UA were abolished by overexpression of NF-\u03baB p65 or TNF-\u03b1.", "population_specificity": "db/db mice and high glucose-induced podocyte models (in vivo and in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:42.250994+00:00"}
{"study_id": 42710, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects and mechanisms of ursolic acid on busulfan-induced oligospermia in mouse models.", "results_summary": "Ursolic acid at 50 mg/kg increased epididymal sperm concentration, improved testicular morphology, regulated hormone levels, and reduced oxidative damage in oligospermia mice. The study also found that ursolic acid upregulated genes related to motor proteins.", "population_specificity": "Male mice with busulfan-induced oligospermia.", "effective_dosage": "10, 30, and 50 mg/kg body weight, administered daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:42.796009+00:00"}
{"study_id": 42711, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effects of Ursolic Acid (UA) on intestinal ischemia/reperfusion injury (IRI) and explore its underlying mechanisms.", "results_summary": "UA improved necroptosis via the RIP1/RIP3/MLKL pathway, reduced necroinflammation through the HMGB1/TLR4/NF-\u03baB pathway, attenuated morphological damage, and enhanced intestinal barrier function. UA's effects were linked to the suppression of STAT3 activation.", "population_specificity": "Mouse model of superior mesenteric artery occlusion/reperfusion and in vitro model of oxygen-glucose deprivation and reperfusion-induced IEC-6 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:45.935976+00:00"}
{"study_id": 42712, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and interstitial fluid drainage abnormalities in a schizophrenia mouse model.", "results_summary": "UA treatment improved behavioral performance, reduced hyperactivity and anxiety symptoms, restored sensorimotor gating function, reversed demyelination, and normalized interstitial fluid drainage and AQP4 protein expression in the schizophrenia mouse model.", "population_specificity": "Female C57BL/6J mice, aged 6-8 weeks.", "effective_dosage": "25 mg/kg UA administered intragastrically.", "study_duration": "One week of UA pretreatment followed by two weeks of drug intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:47.026986+00:00"}
{"study_id": 42713, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy of Ursolic Acid (UA) in mitigating osteoarthritis progression by assessing its anti-inflammatory, chondroprotective, and analgesic effects in a rat model.", "results_summary": "UA demonstrated significant anti-inflammatory effects, downregulated oxidative stress and inflammatory biomarkers (TNF-\u03b1, IL-1\u03b2, NF-\u03baB, MMP-9/TIMP-1), and elevated TGF-\u03b2 levels, suggesting multi-targeted efficacy in OA management. Histopathological and radiographical analyses confirmed UA's chondroprotective and analgesic properties.", "population_specificity": "Rats with induced osteoarthritis via intra-articular carrageenan injection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:47.258208+00:00"}
{"study_id": 42714, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effect of Ursolic Acid on ferroptosis in triple-negative breast cancer stem-like cells (BCSCs) and its potential therapeutic mechanism.", "results_summary": "Ursolic Acid reduced stemness traits and proliferation of BCSCs in vitro and in vivo by promoting ferroptosis, likely through inhibition of the NRF2 pathway. The study demonstrated UA's potential to address metastasis and drug resistance in triple-negative breast cancer.", "population_specificity": "Triple-negative breast cancer stem-like cells (MDA-MB-231 and BT-549 cell-derived) and BALB/c-nude mice xenograft models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:47.478160+00:00"}
{"study_id": 42715, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antibacterial efficacy of ursolic acid (UA) against Staphylococcus aureus and other bacteria associated with bovine mastitis and to clarify its mechanistic basis.", "results_summary": "UA demonstrated robust antibacterial activity against Gram-positive bacteria, including S. aureus, with higher purity UA showing lower MIC values. It disrupted cell walls, impaired protein synthesis, and increased ROS production, but had no effect on E. coli.", "population_specificity": "Bacterial isolates (S. aureus, Streptococcus spp., Enterococcus faecalis) and clinical S. aureus isolates from bovine mastitis.", "effective_dosage": "MIC values ranged from 39 \u03bcg/mL (98% UA) to 625 \u03bcg/mL (10% UA) for S. aureus; MBC values for clinical isolates were 78-156 \u03bcg/mL.", "study_duration": "Not specified", "interactions": "Synergistic effects noted when combined with antibiotics (FICI assessed).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:49.742565+00:00"}
{"study_id": 42716, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic potential of Ursolic Acid (UA) on lupus nephritis (LN) and its underlying mechanism, focusing on NLRP3 inflammasome inhibition.", "results_summary": "UA significantly alleviated LN in MRL/lpr mice, reducing proteinuria, immune cell infiltration, and renal damage. It also inhibited IL-1\u03b2, IL-18, caspase-1 secretion, pyroptosis, and ASC speck formation in vitro, and suppressed SUMO1-mediated SUMOylation of NLRP3.", "population_specificity": "MRL/lpr lupus-prone mice and primary mouse glomerular mesangial cells (GMCs) and SV40-MES-13 cells.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:51.538446+00:00"}
{"study_id": 42717, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of a hyaluronic acid-ursolic acid (HA-UA) conjugate for targeted co-delivery with paclitaxel (PTX) in treating triple-negative breast cancer (TNBC).", "results_summary": "The HA-UA/PTX nanoparticles demonstrated enhanced cellular uptake, higher cytotoxicity, apoptosis, and mitochondrial depolarization compared to PTX alone, with superior antitumor efficacy (90% tumor inhibition rate) and improved pharmacokinetic properties in vivo.", "population_specificity": "Triple-negative breast cancer (TNBC) models (MDA-MB-231 cells and 4T1 tumor model).", "effective_dosage": "Not specified (13.85 mol% UA in HA-UA conjugate).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:51.660942+00:00"}
{"study_id": 42718, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of ursolic acid (UA) in addressing psoriasis-related inflammation and keratinocyte hyperproliferation, focusing on its anti-inflammatory and pro-apoptotic properties.", "results_summary": "The study found that UA effectively limited IL-6 and IL-8 production, reduced expression of psoriatic biomarkers (S100A7, S100A8, S100A9), and mitigated keratinocyte hyperproliferation via non-inflammatory apoptosis. Hybrid formulations, particularly bi-gel, enhanced UA's bioavailability and effectiveness compared to UA alone.", "population_specificity": "In vitro models using skin and immune cells.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:51.691574+00:00"}
{"study_id": 42719, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the pharmacological mechanisms of ursolic acid on metabolic dysfunction-associated steatotic liver disease (MASLD), focusing on its potential to modulate immune inflammation via the SPP1-mediated Th17 cell differentiation pathway.", "results_summary": "Ursolic acid suppressed SPP1 protein activity, reducing Th17 cell differentiation and inflammatory cascades in MASLD, suggesting a therapeutic role in ameliorating immune inflammation via the ERK signaling pathway orchestrated by ITGB1 and CD44.", "population_specificity": "Gene knockdown mice and isolated CD4+ T cells.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:54.349891+00:00"}
{"study_id": 42721, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how ursolic acid inhibits glioblastoma progression by targeting TGF\u03b2-triggered EMT and angiogenesis.", "results_summary": "Ursolic acid effectively blocked glioblastoma cell spread, movement, and invasion, reduced TGF\u03b2 and EMT markers (snail, vimentin), and showed dose-dependent angiogenesis inhibition via decreased VEGF. It also significantly inhibited tumor growth in a glioblastoma xenograft mouse model.", "population_specificity": "Glioblastoma cell lines (U87, U251) and human umbilical vein endothelial cells (HUVECs), plus a glioblastoma xenograft mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:56.228143+00:00"}
{"study_id": 42720, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the efficacy of Ursolic acid in alleviating neuropathic pain in rats with spinal nerve ligation (SNL) and its mechanism of action via MAPK1 targeting and gut microbiota modulation.", "results_summary": "Ursolic acid reduced neuropathic pain in SNL rats by increasing plantar withdrawal latency and paw withdrawal threshold, modulating gut microbiota, and targeting MAPK1 to decrease inflammatory factors. Overexpression of MAPK1 counteracted these effects.", "population_specificity": "Rats with surgically induced spinal nerve ligation (SNL).", "effective_dosage": "Different concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:56.231441+00:00"}
{"study_id": 42722, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the molecular mechanisms of ursolic acid (UA) in treating bladder cancer using network pharmacology and molecular docking, followed by in vitro validation.", "results_summary": "UA demonstrated anti-tumor effects on bladder cancer through multiple targets and pathways, with stable binding to core genes (STAT3, VEGFA, CASP3, TP53, IL1B, CCND1) and induction of apoptosis via the PI3K/Akt pathway.", "population_specificity": "Bladder cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:56.469325+00:00"}
{"study_id": 42726, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the mitochondrial targeting ability and anti-tumor efficacy of ursolic acid (UA) encapsulated in TPP-PAEEP-PEG-PLLA nanoparticles.", "results_summary": "The study found that UA-loaded nanoparticles exhibited improved bioavailability and more pronounced anti-tumor effects compared to free UA, with good mitochondrial targeting capability.", "population_specificity": "In vitro cell models (specific cell type not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:59.077392+00:00"}
{"study_id": 42723, "supplement_id": 1644, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a dual-targeting nanoplatform (TDTD@UA/HA micelles) co-delivering ursolic acid (UA) and doxorubicin (DOX) in overcoming cancer multidrug resistance (MDR).", "results_summary": "The study found that TDTD@UA/HA micelles effectively targeted mitochondria, released UA and DOX under ROS triggers, and disrupted mitochondrial function, restoring chemosensitivity in MCF-7/ADR cells. The nanoplatform demonstrated potent anticancer efficacy with no significant toxicity in MDR tumor-bearing nude mice.", "population_specificity": "MCF-7/ADR cells (doxorubicin-resistant breast cancer cells) and MDR tumor-bearing nude mice.", "effective_dosage": "UA loading capacity: 9.06% in micelles (specific dosage not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:00.108519+00:00"}
{"study_id": 42727, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary 23-hydroxy ursolic acid (23-OH UA) protects mice against the onset and progression of experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS).", "results_summary": "Dietary 23-OH UA reduced EAE disease severity by 48%, incidence by 49%, and ameliorated disease-associated weight loss, but did not affect T cell responses (IL-17 or IFN-\u03b3 production).", "population_specificity": "Female C57BL/6 mice", "effective_dosage": "0.2% wgt/wgt in diet", "study_duration": "5 weeks pre-EAE induction and 30 days post-immunization", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:00.442723+00:00"}
{"study_id": 42725, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of Ursolic Acid (UA) in addressing muscle atrophy and organ dysfunction in cancer cachexia and to reveal the mechanisms involved.", "results_summary": "UA dose-dependently ameliorated muscle atrophy in C2C12 myotubes and protected CT26 tumor-bearing mice against body weight loss, increased skeletal muscle and fat mass, and improved food intake. It also downregulated inflammatory markers and reversed myocardial dysfunction indicators.", "population_specificity": "CT26 tumor-bearing mice and C2C12 myotubes (in vitro).", "effective_dosage": "Not specified (dose-dependent in vitro, in vivo dosage not detailed).", "study_duration": "38 days (in vivo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:01.043174+00:00"}
{"study_id": 42728, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of an oleolyte rich in ursolic acid (UA) from white grape pomace (WGPO) on neuronal regeneration in mice with induced sciatic nerve resection.", "results_summary": "WGPO reduced muscle atrophy, increased muscle fiber number and diameter, decreased Atrogin-1 and Murf-1 expression, and improved neuromuscular junction innervation. The PRE-WGPO group showed enhanced nerve fiber reformation, higher myelin protein zero levels, and pro-hypertrophic effects in non-denervated muscles.", "population_specificity": "Mice with induced sciatic nerve resection", "effective_dosage": "Not specified", "study_duration": "10 days (PRE-WGPO group received treatment 10 days prior to injury)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:03.502287+00:00"}
{"study_id": 42730, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanism of ursolic acid (UA) against acute B lymphoblastic leukaemia (B-ALL) using network pharmacology, molecular docking, and experimental verification.", "results_summary": "UA decreased the viability of Reh cells in a concentration- and time-dependent manner and induced apoptosis and pyroptosis by upregulating the JNK signalling pathway, demonstrating anti-B-ALL effects.", "population_specificity": "Reh cells (a B-ALL cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:04.681430+00:00"}
{"study_id": 42731, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antimetastatic effect of Ursolic Acid (UA) on colon cancer by targeting ARL4C and the AKT/mTOR signaling pathway.", "results_summary": "UA inhibited colon cancer metastasis in vivo and in vitro by reducing ARL4C and MMP2 protein levels and suppressing the AKT/mTOR pathway. Overexpression of ARL4C reversed UA's inhibitory effects, and UA induced ARL4C ubiquitination, which was blocked by a proteasome inhibitor.", "population_specificity": "Nude mice with a lung metastasis model of colon cancer and human colon cancer cell lines (HCT-116 and SW480).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:06.057914+00:00"}
{"study_id": 42729, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the synergistic anti-tumor effects of ursolic acid (UA) and sorafenib (Sora) when combined in carrier-free nanoparticles (US NPs) for hepatocellular carcinoma (HCC) treatment.", "results_summary": "US NPs demonstrated synergistic inhibition of cancer cell proliferation (HepG2, SMMC7721, H22), reduced migration and adhesion, degraded mitochondrial membrane potential, induced apoptosis, and promoted autophagy. The nanoparticles showed good dispersibility, stability, and potential for improved drug delivery.", "population_specificity": "In vitro (HepG2, SMMC7721, H22 cells) and implied relevance to hepatocellular carcinoma patients.", "effective_dosage": "Not specified (different proportions of UA and Sora used).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:06.523090+00:00"}
{"study_id": 42732, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the targeting and anti-tumor effects of Ursolic Acid (UA) delivered via a novel hyaluronic acid (HA)-targeted liposome system (HA-Lipo/UA) in lung cancer cells.", "results_summary": "HA-Lipo/UA effectively targeted CD44-overexpressing A549 cells, inhibited their proliferation, induced apoptosis, and upregulated ROS, p53, and apoptosis-related proteins in the ARTS pathway, leading to mitochondrial apoptosis. The delivery system showed superior effects compared to monotherapies.", "population_specificity": "CD44-overexpressing A549 lung cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.324710+00:00"}
{"study_id": 42734, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop a novel nanodrug using poly(ursolic acid) (PUA) as a bioactive nanocarrier to enhance renal targeting and therapeutic efficacy for acute kidney injury (AKI).", "results_summary": "PUA nanoparticles effectively scavenged ROS, protected against H2O2-induced cellular damage, improved kidney drug accumulation, and exhibited synergistic anti-inflammatory and antioxidant effects with resveratrol in AKI mouse models.", "population_specificity": "AKI mouse models (in vivo) and H2O2-induced cellular damage (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.949193+00:00"}
{"study_id": 42733, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pharmacological effects and underlying mechanisms of UAOS-Na, a water-soluble derivative of Ursolic Acid, in treating experimental autoimmune encephalomyelitis (EAE) and cuprizone-induced demyelination.", "results_summary": "UAOS-Na delayed EAE onset, reduced incidence, lowered pro-inflammatory cytokine levels, decreased CNS infiltration of immune cells, and attenuated demyelination. It also downregulated key proteins in the MHC-I antigen presentation pathway, reducing CD8 T cell proliferation and CNS infiltration.", "population_specificity": "Mice with EAE or cuprizone-induced demyelination.", "effective_dosage": "30 mg/kg/d and 60 mg/kg/d.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:09.426748+00:00"}
{"study_id": 42735, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the current knowledge on the anticancer properties of Ursolic Acid (UA), focusing on its ability to modulate various cancer hallmarks and its potential as a multitargeted therapy.", "results_summary": "UA demonstrated potent anticancer effects by inhibiting cell proliferation, inducing apoptosis, suppressing angiogenesis, inhibiting metastasis, and modulating the tumor microenvironment. It targeted key signaling pathways (e.g., PI3K/Akt, MAPK/ERK, NF-\u03baB, Wnt/\u03b2-catenin) and showed activity against multiple cancer types (e.g., breast, lung, prostate, colon, liver).", "population_specificity": "Not specified (review of existing literature on various cancer types).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:10.318190+00:00"}
{"study_id": 42737, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to design and test hybrid systems (nanoemulgel-macroemulsion and nanoemulgel-oleogel) as topical vehicles for ursolic acid to evaluate their potential in psoriasis treatment.", "results_summary": "The UA-loaded systems were well tolerated by keratinocyte cells, exhibited suitable pH and stability, and demonstrated controlled release of ursolic acid, suggesting potential as effective topical formulations for psoriasis.", "population_specificity": "Human keratinocyte cell-like HaCaT cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:12.970735+00:00"}
{"study_id": 42736, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of ursolic acid (UA) in inhibiting colorectal cancer (CRC) cell proliferation, cell cycle progression, and promoting apoptosis via the miR-140-5p/TGF-\u03b23 axis.", "results_summary": "UA inhibited HT-29 cell proliferation, blocked cells in the G1 phase, and promoted apoptosis. It increased miR-140-5p expression, decreased TGF-\u03b23, \u03b2-catenin, and cyclin D1, suggesting inhibition of the Wnt/\u03b2-catenin pathway.", "population_specificity": "HT-29 colorectal cancer cells (in vitro study).", "effective_dosage": "10, 20, 30, and 40 \u03bcM concentrations.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:13.122209+00:00"}
{"study_id": 42739, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the literature on Ursolic Acid's effects on nuclear receptors (NRs) and its potential therapeutic benefits for various ailments.", "results_summary": "Ursolic Acid demonstrated significant anti-inflammatory, anti-hyperlipidemic, and hepatoprotective properties by modulating NRs like PPAR, LXR, FXR, and PXR. It also showed promise in treating autoimmune diseases and exhibited antiproliferative effects against certain cancers.", "population_specificity": "Not specified (literature review, not a clinical study)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:14.747880+00:00"}
{"study_id": 42738, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of ursolic acid (UA) combined with resistance or endurance training on antioxidant markers and the Nrf2/Keap1/ARE pathway in the brains of older diabetic rats.", "results_summary": "UA combined with resistance or endurance training showed beneficial effects on Nrf2 and some antioxidant markers (SOD), but no significant effects on CAT, GPx, or GSH. Spatial memory improved in exercise or UA groups, though interactions varied.", "population_specificity": "23-month-old diabetes-induced male Wistar rats", "effective_dosage": "250 mg/kg, daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:15.165692+00:00"}
{"study_id": 42740, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to assess the anti-throat-cancer effects of ursolic acid derivatives (LH-CUAD) and their underlying mechanisms through in vitro and in vivo experiments.", "results_summary": "LH-CUAD significantly inhibited throat cancer cell proliferation and migration, induced apoptosis via mitochondrial pathway activation, and inhibited the Akt/mTOR pathway with low toxicity in both in vitro and in vivo models.", "population_specificity": "Throat cancer cell lines (Hep-2 and FaDu) and Hep-2 tumor-bearing nude mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:16.596812+00:00"}
{"study_id": 42741, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether ursolic acid could inhibit neuroinflammatory responses after cerebral hemorrhage by targeting the NF-\u03baB/NLRP3/GSDMD pathway.", "results_summary": "Ursolic acid inhibited microglial M1 polarization, reduced inflammatory factors (TNF-\u03b1, IL-6, IL-1\u03b2), and suppressed the NF-\u03baB/NLRP3/GSDMD pathway, demonstrating anti-neuroinflammatory effects in both in vivo and in vitro models.", "population_specificity": "Rat models of cerebral hemorrhage and BV2 microglial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:17.753921+00:00"}
{"study_id": 42742, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy of Ursolic Acid (UA) in treating chronic prostatitis (CP) and explore its underlying mechanism of action.", "results_summary": "UA significantly reduced pathological damage and proinflammatory cytokines in CP model rats, inhibited pyroptosis-related proteins (NLRP3, Caspase-1, ASC, GSDMD), and mitigated oxidative stress via the NLRP3 inflammasome-mediated Caspase-1/GSDMD pathway.", "population_specificity": "CP rat models and pyroptosis cell models (in vivo and in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:18.175576+00:00"}
{"study_id": 42743, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify the synergistic mechanistic pathways of curcumin and ursolic acid in prostate cancer therapy through a systematic review.", "results_summary": "The study found that the most common pathways for ursolic acid in prostate cancer were caspase 3/caspase 9, while combined with curcumin, the pathways involved NF-\u03baB, Akt, and androgen receptors. The review highlighted limited human studies on these effects.", "population_specificity": "Prostate cancer (mechanistic and cellular pathways, not specific human population).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:19.122068+00:00"}
{"study_id": 42745, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ursolic acid (UA) combined with 3'3-diindolylmethane (DIM) could suppress the Akt/Gsk-3\u03b2 signaling pathway and activate the Hippo tumor suppressor pathway in esophageal cancer cells.", "results_summary": "UA plus DIM effectively suppressed the Akt/Gsk-3\u03b2 pathway and activated the Hippo pathway, reducing YAP nuclear translocation and enhancing PTEN activation in esophageal cancer cells. In a xenograft mouse model, this combination diminished tumors by targeting these pathways.", "population_specificity": "Esophageal cancer cells and xenograft nude mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:22.590795+00:00"}
{"study_id": 42747, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ursolic Acid (UA) could alleviate inflammatory cardiac injury in experimental autoimmune myocarditis (EAM) and explore its underlying mechanisms, particularly focusing on the Nrf2/HO-1 pathway.", "results_summary": "UA significantly reduced inflammatory infiltration and myocardial fibrosis while improving cardiac function in EAM mice, primarily by inhibiting oxidative stress and upregulating antioxidant factors Nrf2 and HO-1. In vitro experiments confirmed that UA's effects were dependent on the Nrf2/HO-1 pathway.", "population_specificity": "Six-week-old male BALB/c mice with induced experimental autoimmune myocarditis (EAM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:24.481914+00:00"}
{"study_id": 42746, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether and how Ursolic Acid (UA) reduces neuronal damage by correcting the MMP/TIMP imbalance caused by microglia in an in vitro model of ischemic reperfusion injury.", "results_summary": "UA restored cell viability, reduced apoptosis-related markers, and corrected the MMP9/TIMP1 imbalance in SH-SY5Y cells exposed to microglia-conditioned medium after oxygen-glucose deprivation-reoxygenation (OGDR). These effects were mitigated by adding recombinant MMP9 and TIMP1 neutralizing antibody, confirming UA's role in stabilizing the MMP/TIMP balance.", "population_specificity": "In vitro SH-SY5Y neuronal cells and microglia-conditioned medium in an OGDR model.", "effective_dosage": "0.25 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:25.022322+00:00"}
{"study_id": 42748, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of ursolic acid (UA) and oleanolic acid (OA) on depression-like behaviors in a maternal separation-induced mouse model.", "results_summary": "UA relieved anxiety-like behavior in MS-treated mice but did not improve depression-like behaviors as effectively as OA. UA attenuated increases in microglial activation, TNF-\u03b1 expression, and IDO1 mRNA levels, and reversed decreased synaptophysin expression in the hippocampus.", "population_specificity": "Female and male mice subjected to maternal separation (MS), with greater effects observed in female mice.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:25.347083+00:00"}
{"study_id": 42750, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the mechanisms of ursolic acid (UA) in treating atherosclerosis using network pharmacology and bioinformatics.", "results_summary": "UA had 145 targets related to atherosclerosis, with core genes AR and IL1B identified. UA may regulate these genes via methylation, impacting inflammatory responses and signaling pathways like TNF and AGE-RAGE.", "population_specificity": "Not specified (in silico study).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:25.960140+00:00"}
{"study_id": 42751, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the anti-obesity effects of Ursolic Acid (UA) depend on its regulation of gut microbiota and metabolism in obese mice.", "results_summary": "UA intervention shifted the Firmicutes to Bacteroidetes ratio, increased beneficial gut bacteria (Lactobacillus, Bacteroides, Akkermansia), and improved obesity partly through amino acid metabolism. The study suggests UA's potential therapeutic role in diet-induced obesity.", "population_specificity": "Obese mice induced by a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:27.239271+00:00"}
{"study_id": 42749, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Ursolic Acid (UA) on dexamethasone-induced steroid-induced avascular necrosis of the femoral head (SANFH) in vitro and in vivo, focusing on bone marrow mesenchymal stem cells (BMSCs) proliferation, apoptosis resistance, and osteogenic differentiation.", "results_summary": "UA promoted BMSCs proliferation, resisted dexamethasone-induced apoptosis, and enhanced osteogenic differentiation in vitro. In vivo, UA demonstrated bone repair-promoting effects and delayed SANFH progression by inhibiting apoptosis in a mouse model.", "population_specificity": "Mouse bone marrow mesenchymal stem cells (BMSCs) and a mouse model of SANFH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:27.582731+00:00"}
{"study_id": 42752, "supplement_id": 1644, "safety_score": "60", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the in vitro and in vivo effects of a supercritical extract from Cecropia pachystachya leaves (CPE) against Trypanosoma cruzi, the parasite causing Chagas disease.", "results_summary": "CPE showed trypanocidal effects in vitro but worsened infection outcomes in vivo due to its anti-inflammatory activity, leading to higher parasitemia and lower survival rates in treated mice.", "population_specificity": "BALB/c mice infected with Trypanosoma cruzi.", "effective_dosage": "Not specified.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:31.488862+00:00"}
{"study_id": 42744, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of ursolic acid in reducing damage and oxidative stress in cerulein-induced acute pancreatitis in rats.", "results_summary": "Ursolic acid reduced pancreatic and remote organ damage in acute pancreatitis and decreased oxidative stress, as evidenced by higher antioxidant capacity and lower inflammatory markers in the treatment group compared to the acute pancreatitis group.", "population_specificity": "Wistar albino rats (32 animals, divided into 4 groups).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:31.601150+00:00"}
{"study_id": 42754, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the synergistic effect of oncolytic measles virus (MV) and ursolic acid (UA) against hepatocellular carcinoma (HCC) cells, including those with HBV or HCV replication.", "results_summary": "The combination of MV and UA synergistically increased cell death in Huh-7 HCC cells through enhanced apoptosis, oxidative stress, and mitochondrial dysfunction. Similar effects were observed in HCC cells with HBV or HCV genomes.", "population_specificity": "Hepatocellular carcinoma (HCC) cells, including those harboring HBV or HCV replication.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:33.146089+00:00"}
{"study_id": 42753, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a novel Ursolic acid-based hydrogel and evaluate its iodine adsorption capacity for potential pollutant treatment applications.", "results_summary": "The hydrogel demonstrated good iodine adsorption, removing 75.0% from cyclohexane and 66.3% from aqueous solutions within 36 hours, with strong recyclability (82% capacity retention after 5 cycles). The adsorption process was chemisorption-driven and involved multi-site adsorption on heterogeneous surfaces.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not specified", "study_duration": "36 hours (adsorption test)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:33.176481+00:00"}
{"study_id": 42756, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Ursolic Acid (UA) on neuronal apoptosis and inflammation in traumatic brain injury (TBI) mice, focusing on the miR-141-3p/PDCD4/PI3K/AKT signaling pathway.", "results_summary": "UA significantly reduced brain edema, neuronal mortality, oxidative stress, and neuroinflammation in TBI mice. It upregulated miR-141-3p, which in turn inhibited PDCD4 and reactivated the PI3K/AKT pathway, demonstrating neuroprotective effects.", "population_specificity": "TBI-induced mice and neuronal cell injury models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:34.586590+00:00"}
{"study_id": 42755, "supplement_id": 1644, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the mechanism of ursolic acid in treating sepsis by examining its interaction with myeloid differentiation protein-2 (MD-2) and its effects on cytokine release and inflammatory pathways.", "results_summary": "Ursolic acid bound effectively to MD-2, reduced cytokine levels (IL-1\u03b2, IL-6, TNF-\u03b1, NO), and downregulated inflammatory pathway proteins (MD-2, MyD88, p-NF-\u03baB p65, iNOS) in a dose-dependent manner, demonstrating anti-sepsis effects.", "population_specificity": "Raw 264.7 cells (murine macrophage cell line) cultured in vitro.", "effective_dosage": "8, 40, and 100 mg/L ursolic acid.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:34.914530+00:00"}
{"study_id": 42758, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ursolic acid (UA) could inhibit Mycobacterium tuberculosis (Mtb)-induced pyroptosis and necroptosis in macrophages, enhance autophagy, and improve intracellular killing of Mtb.", "results_summary": "UA inhibited Mtb-induced pyroptosis and necroptosis in macrophages, induced autophagy, and enhanced intracellular killing of Mtb by synergistically inhibiting the Akt/mTOR and TNF-\u03b1/TNFR1 signaling pathways. These effects suggest UA could be a potential adjuvant for host-targeted anti-TB therapy by modulating immune responses and reducing excessive inflammation.", "population_specificity": "Macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:36.069583+00:00"}
{"study_id": 42757, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential targets and mechanism of ursolic acid (UA) on gastric cancer (GC) and COVID-19 using network pharmacology and bioinformatics analysis.", "results_summary": "The study identified 32 intersection targets of UA and GC/COVID-19, primarily enriched in FoxO, PI3K/Akt, and ErbB signaling pathways. UA showed strong binding to core targets like PARP1 and MAPK14, suggesting potential therapeutic effects via anti-inflammatory, anti-oxidation, anti-virus, and immune regulation mechanisms.", "population_specificity": "Patients with gastric cancer and COVID-19.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:36.456856+00:00"}
{"study_id": 42759, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role and mechanisms of Ursolic Acid (UA) in treating cancer cachexia, specifically its effects on muscle wasting and inflammatory markers.", "results_summary": "UA attenuated muscle atrophy in C2C12 myotubes and LLC tumor-bearing mice, activated SIRT1, downregulated MuRF1 and Atrogin-1, and suppressed inflammatory cytokines without affecting tumor growth. These effects were reversed by SIRT1 inhibition.", "population_specificity": "Lewis lung carcinoma (LLC) tumor-bearing mice and C2C12 myotubes.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:40.429916+00:00"}
{"study_id": 42761, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer efficacy of ursolic acid-loaded chitosan nanoparticles (UACNP) in DMBA-induced oral carcinoma.", "results_summary": "UACNP reversed DMBA-induced abnormalities in oxidative markers and detoxification cascade, demonstrating tumor-inhibiting effects in experimental oral carcinogenesis.", "population_specificity": "DMBA-induced oral carcinoma in an experimental model (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:40.629116+00:00"}
{"study_id": 42760, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ursolic acid (UA) acts as a natural antagonist of ROR\u03b3 in cancer cells and its potential therapeutic effects in prostate and triple-negative breast cancer.", "results_summary": "UA strongly inhibited ROR\u03b3-dependent transactivation in cancer cells, downregulated AR signaling in prostate cancer, and altered ROR\u03b3-controlled gene programs in TNBC, while digoxin showed no such effects. The study identified ROR\u03b3 as a direct target of UA in cancer cells, suggesting its potential for patient-specific treatment.", "population_specificity": "Prostate cancer (castration-resistant) and triple-negative breast cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:40.784676+00:00"}
{"study_id": 42762, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize existing studies on the effects of ursolic acid and its derivatives against prostate and other urogenital cancers.", "results_summary": "Ursolic acid demonstrated inhibition of human prostate, renal, bladder, and testicular cancer cell proliferation and induced apoptosis. Limited animal studies showed significant tumor volume reduction in xenografted human prostate cancer cells treated with ursolic acid.", "population_specificity": "Human prostate, renal, bladder, and testicular cancer cells; animal models xenografted with human prostate cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:41.634459+00:00"}
{"study_id": 42763, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop self-assembled nanoparticles of ursolic acid (UA NPs) to improve its ability to cross the blood-brain barrier and treat glioblastoma multiforme (GBM).", "results_summary": "UA NPs effectively crossed the blood-brain barrier, induced autophagy and apoptosis in glioblastoma cells, and significantly improved survival time in intracranial xenograft models.", "population_specificity": "Intracranial xenograft mouse models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:42.384807+00:00"}
{"study_id": 42764, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if ursolic acid (UA) could reverse cisplatin resistance in lung cancer cells by inhibiting the Jak2/Stat3 pathway and reducing cancer stem cell enrichment.", "results_summary": "UA inhibited the Jak2/Stat3 pathway, reduced levels of pluripotent stem cell transcription factors (Oct-4, Sox-2, c-Myc), and reversed cisplatin resistance in A549-CisR lung cancer cells. This suggests UA may be effective in overcoming chemotherapy resistance in lung cancer.", "population_specificity": "Human lung cancer cell line A549 and its cisplatin-resistant variant (A549-CisR).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:45.029973+00:00"}
{"study_id": 42765, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hepatoprotective effects of Ursolic Acid (UA) when delivered via UA/Tween 80 nanovesicles (V-UA) and compare its efficacy and targeting ability to liposomal UA (Lipo-UA).", "results_summary": "The study found that V-UA demonstrated superior hepatocyte targeting and higher drug loading capacity compared to Lipo-UA, leading to improved efficacy in treating liver diseases across three disease models. The nanovesicle formulation also stabilized UA and enhanced its cellular uptake in hepatocytes.", "population_specificity": "Liver disease models (specific human or animal population not specified).", "effective_dosage": "Molar ratio of UA to Tween 80 up to 2:1 (specific dosage not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:45.814917+00:00"}
{"study_id": 42766, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ursolic acid (UA) promotes the transition of LPS/IFN\u03b3-activated BV2 microglia from M1 to M2 polarization and if this effect is mediated through PPAR\u03b3 activation.", "results_summary": "UA shifted LPS/IFN\u03b3-activated BV2 microglia from the M1 to M2 phenotype, reduced neurotoxic factors MMP2 and MMP9, and increased anti-inflammatory factor TIMP1. These effects were PPAR\u03b3-dependent, as co-treatment with a PPAR\u03b3 inhibitor reversed them.", "population_specificity": "BV2 microglia (in vitro) and rats (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:46.686613+00:00"}
{"study_id": 42769, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of Ursolic Acid (UA) on hypertrophic scar formation and its mechanism, focusing on fibroblast behavior and the Smad2/3 pathway.", "results_summary": "UA significantly reduced TGF-\u03b2-induced fibroblast proliferation, migration, contractility, and collagen deposition by inhibiting Smad2/3 phosphorylation, likely through binding to the ALK5 protein domain.", "population_specificity": "Fibroblasts isolated from normal skin (NSFBs) and hypertrophic scars (HSFBs), treated with TGF-\u03b2.", "effective_dosage": "0-20 \u03bcM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:49.448730+00:00"}
{"study_id": 42768, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effect of Ursolic Acid (UA) in atopic dermatitis (AD) mice and explore its underlying mechanisms.", "results_summary": "UA significantly reduced dermatitis scores and ear thickness, inhibited skin proliferation and mast cell infiltration, decreased T helper cytokine levels, improved oxidative stress, and modulated the TLR4/NF-\u03baB and Nrf2/HO-1 pathways in AD mice and stimulated HaCaT cells.", "population_specificity": "Balb/c mice with DNCB-induced AD-like lesions and TNF-\u03b1/IFN-\u03b3-stimulated HaCaT cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:49.530441+00:00"}
{"study_id": 42767, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a novel nanomedicine combining Ursolic Acid (UA) and astragaloside IV (AS-IV) for treating non-small cell lung cancer (NSCLC) metastasis through chemotherapy, photothermal therapy, and immunotherapy.", "results_summary": "The nanomedicine significantly improved the aqueous solubility and tumor-targeting ability of UA and AS-IV, enhancing UA-mediated cytotoxicity and anti-metastatic effects against NSCLC cells while boosting AS-IV-mediated immune responses. The combined approach effectively inhibited primary tumor growth and distant metastasis in vitro and in vivo.", "population_specificity": "Non-small cell lung cancer (NSCLC) cells and models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:50.142737+00:00"}
{"study_id": 42770, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antibacterial and anticancer potential of ursolic acid-based hybrid compounds through synthesis, molecular docking, and in vitro studies.", "results_summary": "Several synthesized compounds demonstrated significant antibacterial activity (MIC values of 15.625 \u03bcg/ml) and cytotoxicity against human cancer cells, with compounds 29 and 34 showing better efficacy than ursolic acid. Molecular docking studies indicated favorable binding interactions with EGFR, suggesting potential for anticancer and antimicrobial applications.", "population_specificity": "In vitro studies on bacterial strains and human cancer cell lines (MDA-MB-231, HeLa, and MCF-7).", "effective_dosage": "MIC values of 15.625 \u03bcg/ml for antibacterial activity; IC50 values of 46.99 and 48.18 \u03bcg/ml for cytotoxicity.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:51.360926+00:00"}
{"study_id": 42772, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic effect and potential mechanisms of Ursolic Acid (UA) in protecting against liver injury and hepatic steatosis in an alcoholic liver disease (ALD) mouse model.", "results_summary": "UA significantly reduced alcohol-induced liver injury and hepatic steatosis, ameliorated metabolic disorders, oxidative stress, and inflammation, and activated autophagy via the AMPK-ACC pathway to protect hepatocytes from lipotoxicity.", "population_specificity": "ALD mouse model and AML12/HepG2 cell lines.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:53.268511+00:00"}
{"study_id": 42774, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective potential of ursolic acid (UA) in reversing Alzheimer's disease (AD) pathology and improving cognitive deficits in an A\u03b21-42-induced AD mouse model.", "results_summary": "UA significantly reduced A\u03b2 plaques, restored neuronal density (evidenced by DCX and Ki-67 immunoreactivity), and improved social affiliation in A\u03b21-42-treated mice, with effects comparable to donepezil. Molecular docking studies supported UA's binding affinity to neurogenesis markers.", "population_specificity": "Male BALB/c mice with A\u03b21-42-induced AD-like pathology.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:55.911666+00:00"}
{"study_id": 198532, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Ursolic Acid supplementation on cardiometabolic risk factors in humans.", "results_summary": "The study found that Ursolic Acid supplementation (50.94 to 450 mg/day) did not significantly alter body weight, BMI, waist circumference, body fat percentage, lean body mass, blood pressure, fasting glucose, insulin, triglycerides, or HDL compared to control groups.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "50.94 to 450 mg/day", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:57.455506+00:00"}
{"study_id": 42775, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer properties of Ursolic Acid (UA), including its mechanisms of action and potential to inhibit cancer cell production and proliferation.", "results_summary": "The study found that Ursolic Acid (UA) exhibits anti-inflammatory, anticancer, and anti-carcinogenic properties, inhibits cancer cell viability and proliferation, and prevents tumor angiogenesis and metastatic activity.", "population_specificity": "Not specified (focused on cancer cell lines and animal models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:57.673593+00:00"}
{"study_id": 198533, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Ursolic Acid supplementation combined with exercise on metabolic syndrome components in postmenopausal women.", "results_summary": "Ursolic Acid supplementation showed greater improvement in handgrip strength compared to placebo but did not significantly affect waist circumference or other metabolic syndrome components. Both groups had similar remission rates for metabolic syndrome.", "population_specificity": "Postmenopausal women (61 \u00b1 7 years)", "effective_dosage": "450 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:58.950836+00:00"}
{"study_id": 198534, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of ursolic acid as an adjunctive treatment for obesity-mediated metabolic abnormalities, focusing on adiposity, energy expenditure, and skeletal muscle mass.", "results_summary": "The study found that ursolic acid enhances thermogenesis, increases skeletal muscle mass, and improves physical fitness through various physiological and molecular mechanisms, suggesting its potential as a therapy for obesity-related metabolic issues.", "population_specificity": "Mice and humans (based on 17 eligible studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:59.383167+00:00"}
{"study_id": 44113, "supplement_id": 1645, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antimicrobial activity of Arctostaphylos uva-ursi leaf extract against Cutibacterium acnes and its potential as a therapeutic option for acne vulgaris.", "results_summary": "The study found that Uva ursi extract exhibited significant antimicrobial activity against planktonic C. acnes (MIC90 of 0.6 mg/mL) and disrupted biofilm formation. It also inhibited pro-inflammatory cytokine secretion without affecting human keratinocyte viability.", "population_specificity": "In vitro study using planktonic C. acnes and immortalized human keratinocytes (HaCaT cells).", "effective_dosage": "0.3 mg/mL and 0.6 mg/mL (sub-MIC and MIC concentrations).", "study_duration": "24 and 48 hours for cell viability and cytokine assays.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:03.368749+00:00"}
{"study_id": 44114, "supplement_id": 1645, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the chemical composition and effects of a dry alcohol extract from bearberry leaves, enriched with cysteine, on pancreatic function in rats with dexamethasone-induced insulin resistance.", "results_summary": "The study found that the bearberry leaves extract, especially when enriched with cysteine, had hypoglycemic and pancreatic protective effects, improving hyperglycemia, insulin resistance, and beta cell reduction in the treated animals.", "population_specificity": "Rats with dexamethasone-induced insulin resistance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:03.806390+00:00"}
{"study_id": 44117, "supplement_id": 1645, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how intrinsic biological, climatic, and geographic factors affect phenolic compound variation in wild bearberry populations across the Iberian Peninsula.", "results_summary": "The study found significant variation in phenolic compounds, including arbutin, catechin, and myricetin, influenced by geographic and climatic factors. Elite genotypes with higher antioxidant capacity were identified.", "population_specificity": "42 wild populations of bearberry (Arctostaphylos uva-ursi) across a latitude and altitude gradient in the Iberian Peninsula.", "effective_dosage": "Not specified", "study_duration": "Leaves were collected over a three-year period (2014-2016).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:06.596575+00:00"}
{"study_id": 44116, "supplement_id": 1645, "safety_score": "70", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine if initial treatment with uva ursi (UU) reduces antibiotic use in women with uncomplicated UTIs without increasing symptom burden or complications compared to antibiotic treatment.", "results_summary": "Uva ursi reduced antibiotic use by 63.6% but resulted in a higher symptom burden (136.5% compared to control) and more cases of pyelonephritis (8 vs. 2 in the fosfomycin group). Adverse events were similar between groups.", "population_specificity": "Adult women with suspected uncomplicated UTIs in Germany.", "effective_dosage": "105 mg, 3 \u00d7 2 tablets daily for 5 days.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:06.767291+00:00"}
{"study_id": 44119, "supplement_id": 1645, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine if Uva ursi, alongside a delayed antibiotic prescription, could relieve UTI symptoms and reduce antibiotic consumption in women with acute uncomplicated UTIs.", "results_summary": "The study found no evidence that Uva ursi reduced symptom severity or antibiotic consumption compared to placebo. However, ibuprofen advice significantly reduced antibiotic use without increasing complications.", "population_specificity": "Women aged 18-70 years with symptoms of dysuria, urgency, or frequency of urination and suspected lower UTI.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:07.016501+00:00"}
{"study_id": 42773, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to investigate the molecular mechanism of ursolic acid in treating osteoporosis and identify its potential therapeutic targets and signaling pathways.", "results_summary": "The study identified 43 common target genes between ursolic acid and osteoporosis, with 24 core genes (e.g., TP53, IL6, VEGFA) implicated in pathways like apoptosis and inflammation. Molecular docking showed strong binding activity (binding energies < -5 kcal/mol), suggesting ursolic acid may treat osteoporosis by regulating these genes.", "population_specificity": "Not specified (in silico and database analysis)", "effective_dosage": "Not available", "study_duration": "Not applicable (computational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:07.291324+00:00"}
{"study_id": 44120, "supplement_id": 1645, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether initial treatment with Uva ursi (Arctostaphylos uva-ursi) could reduce antibiotic use in women with uncomplicated UTIs without significantly increasing symptom burden or complications.", "results_summary": "The study compared Uva ursi to fosfomycin, with the primary outcomes being antibiotic use reduction and symptom burden. The trial would be considered positive if Uva ursi showed superiority in reducing antibiotic courses and non-inferiority in symptom burden compared to fosfomycin.", "population_specificity": "Women aged 18-75 with suspected UTIs and at least two symptoms (dysuria, urgency, frequency, or lower abdominal pain).", "effective_dosage": "3 \u00d7 2 arbutin 105 mg daily for 5 days.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:09.256661+00:00"}
{"study_id": 42771, "supplement_id": 1644, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Ursolic Acid (UA) could prevent cardiac dysfunction induced by ischemia/reperfusion (I/R) injury and explore its underlying mechanisms.", "results_summary": "UA administration significantly reduced I/R-induced cardiac dysfunction, infarct size, apoptosis, and oxidative stress in mice by activating immunoproteasome-mediated PP2A degradation and AMPK-PGC1\u03b1 signaling, improving mitochondrial function. In vitro, UA also prevented hypoxia/reperfusion-induced cardiomyocyte apoptosis and mitochondrial dysfunction.", "population_specificity": "Male wild-type mice and in vitro cardiomyocytes.", "effective_dosage": "80 mg/kg intraperitoneally.", "study_duration": "24 hours post-I/R injury.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:11.592014+00:00"}
{"study_id": 44121, "supplement_id": 1645, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Uva ursi, alone or with ibuprofen, provides symptom relief and reduces antibiotic use in adult women with suspected UTIs.", "results_summary": "The abstract does not report specific results for Uva ursi, but the study design suggests it will evaluate symptom severity and antibiotic use as primary and secondary outcomes.", "population_specificity": "Adult women with suspected urinary tract infection presenting to primary care.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:12.004421+00:00"}
{"study_id": 44122, "supplement_id": 1645, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of a low dose of Arctostaphylos uva-ursi on rabbits, focusing on hematological, biochemical, and histopathological changes.", "results_summary": "The study found gender-based variations in hematological and biochemical parameters but no significant pathology in heart, stomach, liver, or kidney tissues at a dose of 25 mg/kg/day. Urine analysis results were comparable to standard and control treatments.", "population_specificity": "Rabbits", "effective_dosage": "25 mg/kg/day", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:12.069269+00:00"}
{"study_id": 44123, "supplement_id": 1645, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Uva ursi's active principles, including their biogenesis, isolation, qualitative and quantitative differences during the vegetative period, and changes during technological treatment and pharmacological activity.", "results_summary": "The study highlights Uva ursi's phenolic glucosides as key active principles responsible for its disinfective effect on the urinary tract, supporting its pharmaceutical use in medicinal teas. The research also examines variations in active principles during different growth stages and processing.", "population_specificity": "Not specified (general pharmaceutical application)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:14.904161+00:00"}
{"study_id": 43577, "supplement_id": 1646, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of valerian for sleep disturbances, particularly insomnia, through an umbrella review of systematic reviews.", "results_summary": "The study found that valerian has a good safety profile but no evidence of efficacy for treating insomnia. Subjective sleep quality improvements were reported, but these were not supported by quantitative or objective measurements.", "population_specificity": "Young adults with sleep-onset difficulties.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:15.050259+00:00"}
{"study_id": 43575, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether valerian hydroalcoholic extract, alone or combined with exercise, could improve endothelial dysfunction and antioxidant levels in diabetic rats.", "results_summary": "The study found that the combination of valerian extract and exercise improved vascular vasodilator response and increased levels of antioxidants (GPx and SOD) in diabetic rats. Valerian extract alone showed beneficial effects, but the synergistic effect with exercise was more pronounced.", "population_specificity": "Diabetic Wistar rats", "effective_dosage": "200 mg/kg, oral", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:15.490544+00:00"}
{"study_id": 43576, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the anti-insomnia effects of valerian volatile oil (VVO) and investigate its potential mechanism of action through chemical analysis, network pharmacology, and experimental validation.", "results_summary": "The study found that VVO significantly reduced autonomous activity, decreased sleep latency, and extended sleep duration in mice, with molecular interactions suggesting effects on targets like MAOB. Western blot experiments confirmed decreased MAOB expression in the cerebral cortex.", "population_specificity": "Mice (animal study)", "effective_dosage": "100 mg/kg (high dose)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:16.863140+00:00"}
{"study_id": 43579, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of valerian and gabapentin on restless legs syndrome (RLS) and sleep quality in hemodialysis (HD) patients.", "results_summary": "Valerian was less effective than gabapentin in improving RLS but equally effective in improving sleep quality, with no statistically significant difference between the two groups for sleep outcomes.", "population_specificity": "Hemodialysis (HD) patients with restless legs syndrome.", "effective_dosage": "Not specified (administered 1 hour before bedtime).", "study_duration": "1 month per phase (with a 1-month washout period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:17.583537+00:00"}
{"study_id": 43582, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the active components and mechanisms of action of valerian volatile oil in treating insomnia using a PCPA-induced rat model.", "results_summary": "Valerian essential oil prolonged sleep duration and alleviated insomnia-induced tension and anxiety in rats, likely by upregulating 5-HT1AR and activating the serotonergic synapse pathway to increase 5-HT and GABA expression.", "population_specificity": "SD rats with PCPA-induced insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:19.817477+00:00"}
{"study_id": 43581, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antinociceptive (pain-relieving) effects of a valerian-hops combination in mice to justify its potential use as a safe and effective analgesic.", "results_summary": "The valerian-hops combination at 100 and 200 mg/kg significantly reduced pain responses in multiple tests (acetic acid-induced writhing, formalin and glutamate-induced paw licking, and tail immersion), with effects partially mediated by the opioid system.", "population_specificity": "Swiss albino mice", "effective_dosage": "50, 100, and 200 mg/kg", "study_duration": "Not specified", "interactions": "Naloxone (opioid receptor antagonist) opposed the antinociceptive effect in the tail immersion test.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:20.766512+00:00"}
{"study_id": 43583, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the pharmacological activity of Valerian extract capsule (VEC) in treating gastrointestinal diseases, focusing on its gastroprotective and spasmolytic effects.", "results_summary": "VEC reduced gastric lesions and mucosal damage, enhanced antioxidant and cytoprotective markers, and alleviated inflammatory mediators. It also decreased smooth muscle contraction and promoted intestinal transit in mice.", "population_specificity": "Sprague-Dawley rats and C57BL/6 mice.", "effective_dosage": "124, 248, 496 mg/kg (rats); 248-992 mg/kg (mice).", "study_duration": "3 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:22.044242+00:00"}
{"study_id": 43585, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of Valerian extract on sleep spindles and anxiety in a rat model of chronic neuropathic pain.", "results_summary": "Valerian treatment repaired neuropathy-induced allodynia, decreased REM sleep, increased non-REM sleep, and improved sleep spindle density and frequency in neuropathic conditions.", "population_specificity": "Male rats with chronic constriction injury (CCI) or sham surgery.", "effective_dosage": "400mg/kg", "study_duration": "6 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:22.627376+00:00"}
{"study_id": 43584, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the role of valerian in treating postoperative sleep disturbances and compare its usage to other sleep medications.", "results_summary": "Valerian was the second most used sleep medication (26.4%) after benzodiazepines (36.9%), primarily as monotherapy. It was more common in women, elderly patients, and those with prolonged hospital stays, suggesting its clinical relevance for these groups.", "population_specificity": "21,168 urological, gynecological, and general surgical patients at a German university medical center (2015\u20132020).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:24.065234+00:00"}
{"study_id": 43586, "supplement_id": 1646, "safety_score": "70", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the cytotoxicity and oxidative stress effects of valerian root extract in human liver hepatocellular carcinoma (HepG2) and human colorectal adenocarcinoma (Caco2) cell lines.", "results_summary": "Valerian root extract showed cytotoxicity with IC50 values of 936.6 \u00b5g/mL in HepG2 and 1097.5 \u00b5g/mL in Caco2 cell lines but did not induce oxidative stress. The study concluded that valerian may not be effective for cancer treatment and could pose public health risks, though it may be safe at tolerated concentrations.", "population_specificity": "Human liver hepatocellular carcinoma (HepG2) and human colorectal adenocarcinoma (Caco2) cell lines.", "effective_dosage": "Not specified (IC50 values provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:25.897549+00:00"}
{"study_id": 43587, "supplement_id": 1646, "safety_score": "40", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of valerian treatment on maternal care, toxicity, milk composition in postpartum rats, and its impact on offspring development, memory, and anxiety behavior.", "results_summary": "Valerian did not alter maternal toxicity or care behavior but increased lactose and reduced protein in milk at higher doses. Offspring development was unaffected, but long-term memory impairment was observed in female offspring at 1000 mg\u00b7kg-1\u00b7day-1.", "population_specificity": "Postpartum Wistar rats and their offspring.", "effective_dosage": "500, 1000, or 2000 mg\u00b7kg-1\u00b7day-1 (oral gavage).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:26.174102+00:00"}
{"study_id": 43588, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of valerian and lemon balm as an adjunct to quetiapine in reducing agitation and delirium in critically ill ICU patients.", "results_summary": "The study found that adding Neurogol (valerian and lemon balm) to quetiapine significantly reduced agitation and shortened ICU stay, with no adverse effects reported. However, there was no significant difference in delirium improvement between the treatment and placebo groups.", "population_specificity": "Critically ill adult ICU patients with delirium and agitation.", "effective_dosage": "5 mL of Neurogol syrup (valerian and lemon balm combination) every 12 hours.", "study_duration": "5 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:27.091054+00:00"}
{"study_id": 43589, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of valerian on sleep quality, depression, and state anxiety in hemodialysis patients.", "results_summary": "Valerian significantly improved sleep quality, reduced depression, and alleviated state anxiety in hemodialysis patients, with greater effects observed in the valerian group compared to placebo. The crossover phase confirmed these benefits, though the magnitude of improvement varied between groups.", "population_specificity": "Hemodialysis patients", "effective_dosage": "Not specified (administered one hour before sleep nightly)", "study_duration": "One month per phase (with a one-month washout period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:28.791238+00:00"}
{"study_id": 43590, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if valerian, particularly its active ingredient valeric acid, could inhibit breast cancer cell growth and induce epigenetic changes related to histone deacetylase (HDAC) inhibition and DNA methylation.", "results_summary": "Aqueous valerian extract and valeric acid reduced breast cancer cell proliferation, migration, colony formation, and 3D formation in vitro, along with decreased HDAC activity and global DNA hypomethylation, suggesting potential anti-tumorigenic effects via epigenetic modifications.", "population_specificity": "Breast cancer cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:29.377689+00:00"}
{"study_id": 43591, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the effect of valerian root extract on sleep quality in patients after coronary artery bypass graft (CABG) surgery.", "results_summary": "Valerian root extract significantly improved sleep quality in various dimensions (total sleep quality, sleep latency, sleep duration, sleep efficiency, and daytime dysfunction) compared to placebo, with no significant adverse effects on prothrombin time or partial thromboplastin time.", "population_specificity": "Patients who underwent CABG surgery.", "effective_dosage": "530 mg of valerian capsules per night.", "study_duration": "30 nights.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:30.746276+00:00"}
{"study_id": 43592, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how methionine and phosphate concentrations affect cadmium (Cd) uptake and translocation in Valeriana officinalis L.", "results_summary": "Methionine reduced Cd accumulation in roots by up to 40% but increased Cd uptake in shoots by 50%. Phosphate levels influenced Cd retention in roots, with higher levels increasing Cd accumulation in the presence of methionine.", "population_specificity": "Valeriana officinalis L. seedlings", "effective_dosage": "400 \u03bcM methionine, 10 \u03bcM Cd, and phosphate concentrations of 900, 1200, and 1500 \u03bcM", "study_duration": "4 days (Cd exposure) after 2 weeks of phosphate treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:32.941563+00:00"}
{"study_id": 43593, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to update and re-evaluate existing data on Valerian's effectiveness for sleep problems and associated disorders, while investigating reasons for inconsistent outcomes in previous studies.", "results_summary": "Valerian showed potential as a safe and effective herb for improving sleep and reducing anxiety, with inconsistent outcomes possibly linked to variable extract quality. Combining it with appropriate herbal partners may optimize therapeutic benefits, and no severe adverse events were reported.", "population_specificity": "Subjects aged 7 to 80 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:33.363066+00:00"}
{"study_id": 43596, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of Valerian on cognitive disorders and electroencephalography (EEG) in hemodialysis patients.", "results_summary": "Valerian significantly improved cognitive scores in hemodialysis patients in both treatment periods, but no significant changes were observed in EEG results.", "population_specificity": "Hemodialysis patients (n=39)", "effective_dosage": "Valerian capsules taken 60 minutes before bedtime", "study_duration": "One month per treatment period, with a one-month wash-out between periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:33.616611+00:00"}
{"study_id": 43597, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and tolerance of Valerian as an alternative treatment for insomnia in geriatric populations.", "results_summary": "The study suggests Valerian is considered an effective and suitable alternative for treating sleep disorders in aged people, though it emphasizes non-pharmacological approaches as first-line therapy.", "population_specificity": "Geriatric individuals with sleep disorders.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:34.798427+00:00"}
{"study_id": 43594, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether valerian root could reduce the impact, disability, and severity of tension-type headaches.", "results_summary": "The study found that valerian root significantly reduced the impact of headaches on daily living performance, disability, and severity compared to placebo, with all results showing statistical significance (p<0.001).", "population_specificity": "88 participants with tension-type headache, average age 34.9 (\u00b18.7) years.", "effective_dosage": "530 mg of valerian root extraction (Sedamin\u00ae capsule), two capsules daily.", "study_duration": "One month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:35.377917+00:00"}
{"study_id": 43598, "supplement_id": 1646, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the efficacy and safety of valerian in preventing neuropsychiatric adverse effects of efavirenz in HIV-positive patients.", "results_summary": "Valerian significantly improved sleep and anxiety compared to placebo in HIV-positive patients on efavirenz. Dizziness and nausea were common but not significantly different between groups.", "population_specificity": "HIV-positive patients receiving efavirenz-based ART.", "effective_dosage": "530 mg nightly, 1 hour before sleep.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:36.478252+00:00"}
{"study_id": 43599, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of Valerian on the severity and frequency of hot flashes in postmenopausal women.", "results_summary": "Valerian significantly reduced the severity of hot flashes at one and two months compared to placebo, and the frequency of hot flashes was significantly reduced after two months. Health-care providers should consider Valerian effective for menopausal women with hot flashes.", "population_specificity": "60 postmenopausal women aged 45-55 years in Hamadan, Iran.", "effective_dosage": "530 mg capsule twice per day.", "study_duration": "Two months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:38.005975+00:00"}
{"study_id": 43601, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to establish a screening method for psychoactive efficacy and test the effects of Valeriana officinalis crude root extracts on zebrafish larval behavior and neural activity.", "results_summary": "Valerian extract reversed PTZ-altered swimming behaviors in zebrafish larvae and strongly regulated neural activity-related genes, supporting its psychoactive efficacy. Higher doses of Valerian affected swimming independently of PTZ.", "population_specificity": "Zebrafish larvae", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:40.471382+00:00"}
{"study_id": 43600, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of Valerian root extract on the intensity of PMS symptoms in female students.", "results_summary": "The study found that Valerian root extract significantly reduced emotional, behavioral, and physical PMS symptoms in the intervention group compared to placebo, with statistical significance (P < 0.001). No significant difference was observed in the control group.", "population_specificity": "100 female students with PMS from Islamic Azad University, Tonekabon Branch, Iran.", "effective_dosage": "2 pills daily (extract amount not specified) in the last seven days of the menstrual cycle.", "study_duration": "3 menstrual cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:41.433809+00:00"}
{"study_id": 43602, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of a one-time 1600mg dose of valerian on subjective sedation, standardized field sobriety testing, and driving simulator performance.", "results_summary": "The study found no significant differences in reaction time, sleepiness scales, or driving simulator performance between valerian and placebo. SFST failure rates were also similar between the two conditions.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "1600mg, one-time dose.", "study_duration": "Acute (single-dose) intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:41.541818+00:00"}
{"study_id": 43603, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the application of 1D DOSY (1)H-NMR spectroscopy for characterizing quality and stability markers in Valerian and its combination with hops.", "results_summary": "The study identified diagnostic signals for quality markers in Valerian tinctures, such as valerenic acid and hydroxyvalerenic acid, using NMR techniques without requiring purification. It concluded that 1D DOSY (1)H-NMR could enhance quality assurance for complex herbal mixtures.", "population_specificity": "Commercial tinctures of Valerian (expired and non-expired) and its combination with hops.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:42.706360+00:00"}
{"study_id": 43606, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the fumigant toxicity of valerian essential oil and its components against Japanese termites and assess their acetylcholinesterase inhibition activity.", "results_summary": "Valerian oil showed high fumigant toxicity against Japanese termites after 7 days of exposure, with certain constituents like hydrocinnamyl alcohol and trans-cinnamyl alcohol being major contributors. Only cis-ocimene exhibited strong acetylcholinesterase inhibition activity.", "population_specificity": "Japanese termites (Reticulitermes speratus)", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.348486+00:00"}
{"study_id": 43605, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effects of Valerian on hepatocarcinogenesis in rats, focusing on oxidative DNA damage, cell proliferation, and apoptosis.", "results_summary": "Valerian significantly inhibited the formation of GST-P(+) foci, suppressed oxidative DNA damage, reduced cell proliferation, and induced apoptosis in liver foci, likely through GABA(A)R-mediated signaling.", "population_specificity": "Male F344 rats with diethylnitrosamine (DEN)-initiated hepatocarcinogenesis.", "effective_dosage": "0, 50, 500, and 5000 ppm in drinking water.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.577124+00:00"}
{"study_id": 43604, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of acupressure with 2.5% valerian oil on sleep quality and quantity in patients with acute coronary syndrome (ACS).", "results_summary": "Patients receiving acupressure with valerian oil showed improved sleep quality and quantity compared to the control group, though the difference was not statistically significant compared to acupressure alone. The combination of acupressure and valerian oil had a greater impact on sleep improvement and reducing nighttime awakenings.", "population_specificity": "90 patients with ACS in a coronary intensive care unit (CCU) in Iran.", "effective_dosage": "Two drops of 2.5% valerian oil applied during acupressure for 2 minutes per point, three nights in a row.", "study_duration": "Three nights (total intervention time: 18 minutes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.772021+00:00"}
{"study_id": 43607, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether acetoxy valerenic acid interferes with the anxiolytic action of valerenic acid in Valerian extract.", "results_summary": "Acetoxy valerenic acid abolished the anxiolytic effect of valerenic acid, while the Valerian extract showed no affinity for benzodiazepine binding sites. No effect on body core temperature was observed.", "population_specificity": "Male CD-1 mice and male RjHan:WI rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.978042+00:00"}
{"study_id": 43609, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Valerian on the severity and frequency of hot flashes in menopausal women.", "results_summary": "Valerian significantly reduced both the severity and frequency of hot flashes in menopausal women after 4 and 8 weeks of treatment, with statistically meaningful differences compared to the placebo group. No meaningful difference was observed in the placebo group.", "population_specificity": "Menopausal women experiencing hot flashes.", "effective_dosage": "255 mg capsules, 3 times daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:49.806121+00:00"}
{"study_id": 43610, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether valerian/lemon balm could improve sleep patterns in menopausal women experiencing sleep disorders.", "results_summary": "The study found a significant reduction in sleep disorders among the intervention group (valerian/lemon balm) compared to the placebo group, as measured by the Pittsburgh Sleep Quality Index (PSQI). The results suggest valerian/lemon balm may help alleviate sleep disturbances during menopause.", "population_specificity": "100 women aged 50-60 years with sleep disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:50.559359+00:00"}
{"study_id": 43608, "supplement_id": 1646, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether a fixed combination of valerian root and lemon balm extracts could improve concentration, hyperactivity, and impulsiveness in children with these symptoms but not meeting ADHD criteria.", "results_summary": "The study found significant reductions in symptoms of poor focus (75% to 14%), hyperactivity (61% to 13%), and impulsiveness (59% to 22%), with highly significant improvements in social behavior, sleep, and symptom burden. Only two mild transient adverse reactions were reported.", "population_specificity": "Primary school children (under 12 years) suffering from hyperactivity and concentration difficulties but not meeting ADHD criteria.", "effective_dosage": "640 mg valerian root extract WS(\u00ae) 1014 and 320 mg lemon balm extract WS(\u00ae) 1303 daily.", "study_duration": "7 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:51.108537+00:00"}
{"study_id": 43613, "supplement_id": 1646, "safety_score": "85", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to investigate the efficacy and safety of valerian for treating anxiety and sleep disorders by reviewing existing clinical studies.", "results_summary": "The evidence is insufficient to support valerian's efficacy for anxiety disorders, but it shows some effectiveness for mild to moderate insomnia, though limited by study quality. Valerian is well-tolerated with infrequent and benign side effects.", "population_specificity": "General population with anxiety or sleep disorders (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:53.467030+00:00"}
{"study_id": 43614, "supplement_id": 1646, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether valerian acupressure could improve sleep quality and duration in ICU patients.", "results_summary": "Valerian acupressure increased sleeping hours, reduced wake frequency, and lowered Stanford Sleepiness Scale grades. Heart rate variability data indicated a relaxation response post-intervention.", "population_specificity": "Adult ICU patients (41 in the experimental group, 44 in the control group).", "effective_dosage": "Not specified (acupressure intervention, not oral dosage).", "study_duration": "Single intervention between 7 pm and 10 pm on the second day.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:54.914106+00:00"}
